Search Results

The product title you are looking for is no longer available. Other similar products that may interest you are listed below:

Refine your Search

	Results for 'UK Pharmaceutical Executive Pay'

Title	Publication Date	Price	Relevance
Streamlining Information in the Pharmaceutical Industry with Product Lifecycle Management Solutions (Executive Presentation)	August 2007	£1000	50 %
Bringing Drugs to Market The role of CRM in improving sales & marketing (Executive Presentation)	August 2007	£1000	43 %
Forecasting for the Pharmaceutical Industry	October 2006	£75	38 %
Par Pharmaceutical Companies, Inc. - Financial and Strategic Analysis Review	June 2009	£80	37 %
Business Opportunities in China The impact of the WTO - 2nd Edition	March 2006	£400	36 %
Chugai Pharmaceutical Co. Ltd - Financial and Strategic Analysis Review	April 2009	£80	36 %
EGIS Pharmaceuticals Plc - Strategic Analysis Review	March 2009	£80	34.5 %
Teva Pharmaceutical Industries Limited - Financial and Strategic Analysis Review	July 2009	£80	34.5 %
Alliance Pharmaceutical Corp. - Financial and Strategic Analysis Review	April 2009	£80	34 %
Ono Pharmaceutical Co Deals Partneringdesk briefing	July 2005	£215	34 %
Otsuka Pharmaceutical Co Deals Partneringdesk briefing	July 2005	£215	34 %
Medicis Pharmaceutical Corporation - Financial and Strategic Analysis Review	June 2009	£80	34 %
BioMarin Pharmaceutical Inc. - Financial and Strategic Analysis Review	June 2009	£80	34 %
Ono Pharmaceutical Co., Ltd. - Financial and Strategic Analysis Review	July 2009	£80	33.5 %
West Pharmaceutical Services, Inc. - Financial and Strategic Analysis Review	June 2009	£80	33.5 %
La Jolla Pharmaceutical Company - Financial and Strategic Analysis Review	June 2009	£80	33 %
Fujisawa Pharmaceutical Co Ltd Deals Partneringdesk briefing	July 2005	£215	33 %
Watson Pharmaceuticals, Inc. - Financial and Strategic Analysis Review	June 2009	£80	33 %
Yamanouchi Pharmaceutical Co Ltd Deals Partneringdesk briefing	July 2005	£215	32.5 %
Takeda Pharmaceutical Co Ltd Deals Partneringdesk briefing	July 2005	£215	32.5 %
Takeda Pharmaceutical Company Limited - Financial and Strategic Analysis Review	July 2009	£80	32 %
Daiichi Pharmaceutical Co Ltd Deals Partneringdesk briefing	July 2005	£215	32 %
Lannett Company, Inc. - Financial and Strategic Analysis Review	April 2009	£80	32 %
Akorn, Inc - Financial and Strategic Analysis Review	June 2009	£80	32 %
AMDL, Inc. - Financial and Strategic Analysis Review	June 2009	£80	32 %
AmerisourceBergen Corporation - Financial and Strategic Analysis Review	June 2009	£80	31.5 %
Pharmaceutical Metrics Measuring and Improving R&D Performance	January 2006	£75	31 %
Teva Pharmaceutical Industries Ltd Deals Partneringdesk briefing	July 2005	£215	31 %
Alliance Boots GmbH - Strategic Analysis Review	July 2009	£80	31 %
Managed Markets Market Research: Effective Structures & Activities for Gaining Maximum Payer Access & Insight	December 2008	£2450	31 %
Solvay SA - Financial and Strategic Analysis Review	April 2009	£80	30.5 %
Purdue Pharma L.P. - Strategic Analysis Review	March 2009	£80	30.5 %
Barrier Therapeutics, Inc. - Strategic Analysis Review	March 2009	£80	30.5 %
Mylan Inc. - Financial and Strategic Analysis Review	June 2009	£80	30.5 %
Best Practices in Global Pharmaceutical Launches	January 2007	£4455	30 %
Educating the Market: Creating Value Through Support of Continuing Medical Education	March 2008	£2210	30 %
Eli Lilly and Company - Financial and Strategic Analysis Review	June 2009	£80	30 %
Hikma Pharmaceuticals - Financial and Strategic Analysis Review	June 2009	£80	30 %
Alpha Pro Tech, Ltd. - Financial and Strategic Analysis Review	June 2009	£80	30 %
SkyePharma PLC - Financial and Strategic Analysis Review	July 2009	£80	29.5 %
Pfizer Inc. - Financial and Strategic Analysis Review	April 2009	£80	29.5 %
Shire Plc - Financial and Strategic Analysis Review	April 2009	£80	29.5 %
Legal Aspects of Outsourcing in the Pharmaceutical Industry A Practical Guide	February 2006	£625	29.5 %
Lotus Pharmaceuticals, Inc. - Financial and Strategic Analysis Review	June 2009	£80	29.5 %
Analysis Report on China Antibiotic Industry	June 2007	£125	28.5 %
Depomed, Inc. - Financial and Strategic Analysis Review	June 2009	£80	28.5 %
The Pharmaceutical Market: Estonia	December 2007	£595	28 %
The Pharmaceutical Market: Chile	May 2008	£595	28 %
The Pharmaceutical Market: Peru	June 2008	£595	28 %
The Pharmaceutical Market: Serbia	March 2008	£595	28 %
The Pharmaceutical Market: Australia	June 2009	£595	28 %
The Pharmaceutical Market: Hong Kong	April 2008	£595	28 %
The Pharmaceutical Market: Taiwan	June 2009	£595	28 %
The Pharmaceutical Market: Croatia	February 2008	£595	28 %
The Pharmaceutical Market: Spain	June 2009	£595	28 %
The Pharmaceutical Market: Austria	September 2007	£595	28 %
The Pharmaceutical Market: Israel	July 2008	£595	28 %
The Pharmaceutical Market: Pakistan	June 2009	£595	28 %
The Pharmaceutical Market: Jordan	February 2008	£595	28 %
The Pharmaceutical Market: Bangladesh	May 2008	£595	28 %
Auriga Laboratories Inc. - Financial and Strategic Analysis Review	April 2009	£80	28 %
Sanofi-Aventis - Financial and Strategic Analysis Review	June 2009	£80	28 %
The Pharmaceutical Market: Norway	June 2009	£595	28 %
IMS Health Incorporated - Financial and Strategic Analysis Review	June 2009	£80	28 %
The Pharmaceutical Market: Turkey	March 2008	£595	28 %
The Pharmaceutical Market: Latvia	January 2008	£595	28 %
The Pharmaceutical Market: Hungary	June 2009	£595	28 %
The Pharmaceutical Market: New Zealand	April 2008	£595	28 %
The Pharmaceutical Market: Slovenia	November 2007	£595	28 %
AtheroGenics, Inc. - Financial and Strategic Analysis Review	April 2009	£80	28 %
The Pharmaceutical Market: Denmark	June 2009	£595	28 %
The Pharmaceutical Market: China	July 2008	£595	28 %
AXM Pharma, Inc. - Financial and Strategic Analysis Review	April 2009	£80	28 %
The Pharmaceutical Market: Cuba	June 2009	£595	28 %
The Pharmaceutical Market: Egypt	June 2008	£595	28 %
The Pharmaceutical Market: South Africa	June 2009	£595	28 %
The Pharmaceutical Market: Romania	July 2008	£595	28 %
The Pharmaceutical Market: Brazil Opportunities and Challenges	June 2009	£595	28 %
The Pharmaceutical Market: Greece	October 2007	£595	28 %
Noven Pharmaceuticals, Inc. - Financial and Strategic Analysis Review	June 2009	£80	27.5 %
Echo Therapeutics, Inc. - Financial and Strategic Analysis Review	June 2009	£80	27.5 %
Consort Medical plc - Financial and Strategic Analysis Review	June 2009	£80	27.5 %
Eurand N.V. - Financial and Strategic Analysis Review	June 2009	£80	27.5 %
Warner Chilcott Limited - Financial and Strategic Analysis Review	June 2009	£80	27.5 %
Oramed Pharmaceuticals, Inc. - Financial and Strategic Analysis Review	April 2009	£80	27.5 %
Gedeon Richter Plc. - Financial and Strategic Analysis Review	June 2009	£80	27 %
ART Advanced Research Technologies, Inc. - Financial and Strategic Analysis Review	June 2009	£80	27 %
Acura Pharmaceuticals, Inc. - Financial and Strategic Analysis Review	June 2009	£80	27 %
Watson Pharmaceuticals Inc Deals Partneringdesk briefing	July 2005	£215	27 %
Neurocrine Biosciences, Inc. - Financial and Strategic Analysis Review	June 2009	£80	27 %
Biovail Corp - Financial and Strategic Analysis Review	June 2009	£80	27 %
Enzon Pharmaceuticals, Inc. - Financial and Strategic Analysis Review	April 2009	£80	27 %
Cobalis Corporation - Financial and Strategic Analysis Review	April 2009	£80	27 %
McKesson Corporation - Financial and Strategic Analysis Review	June 2009	£80	27 %
Eisai Co., Ltd. - Financial and Strategic Analysis Review	July 2009	£80	26.5 %
Innovations in Patient-Focused Initiatives Case Studies in Reaching, Engaging and Supporting Patients	July 2009	£2910	26.5 %
GlaxoSmithKline plc - Financial and Strategic Analysis Review	July 2009	£80	26.5 %
STADA Arzneimittel AG - Financial and Strategic Analysis Review	April 2009	£80	26.5 %
Bayer Schering Pharma AG - Financial and Strategic Analysis Review	April 2009	£80	26.5 %
Inyx, Inc. - Financial and Strategic Analysis Review	April 2009	£80	26.5 %
Warnex Inc. - Financial and Strategic Analysis Review	June 2009	£80	26.5 %
The Handbook on Alliances & Deals in Biotech Business	May 2004	£430	26 %
PSS World Medical, Inc. - Financial and Strategic Analysis Review	July 2009	£80	26 %
China Sky One Medical, Inc. - Financial and Strategic Analysis Review	June 2009	£80	26 %
Mitsubishi Tanabe Pharma Corporation - Financial and Strategic Analysis Review	July 2009	£80	26 %
DURECT Corporation - Financial and Strategic Analysis Review	June 2009	£80	26 %
Actavis Group hf. - Strategic Analysis Review	March 2009	£80	25.5 %
Axcan Pharma Inc. - Strategic Analysis Review	March 2009	£80	25.5 %
Biotech Holdings Ltd. - Strategic Analysis Review	March 2009	£80	25.5 %
Ratiopharm direct GmbH - Strategic Analysis Review	March 2009	£80	25 %
China Pharmaceutical Guidebook Series - Vol 4 A Guidebook of Registration Application for Imported Traditional Chinese Medicines and Natural Medicines	February 2007	£475	25 %
China Pharmaceutical Guidebook Series - Vol 1 A Comprehensive Guidebook for Foreign Pharmaceutical Companies	February 2007	£475	25 %
Rewarding & Recognizing Top-Performing Sales People	March 2008	£2210	25 %
Apotex, Inc. - Strategic Analysis Review	June 2009	£80	25 %
Baxter International Inc Deals Partneringdesk briefing	July 2005	£215	25 %
Shire Pharmaceuticals Group PLC Deals Partneringdesk briefing	July 2005	£215	25 %
AlphaRx, Inc. - Strategic Analysis Review	March 2009	£80	25 %
Abbott Laboratories Deals Partneringdesk briefing	July 2005	£215	24.5 %
APP Pharmaceuticals, Inc. - Strategic Analysis Review	June 2009	£80	24.5 %
Chr. Hansen Holding AS - Strategic Analysis Review	March 2009	£80	24.5 %
Les Laboratoires Servier - Strategic Analysis Review	June 2009	£80	24 %
MGI Pharma Inc - Strategic Analysis Review	March 2009	£80	24 %
Bioxel Pharma Inc. - Financial and Strategic Analysis Review	April 2009	£80	24 %
Johnson & Johnson Deals Partneringdesk briefing	July 2005	£215	24 %
Biogen Idec Deals Partneringdesk briefing	July 2005	£215	23.5 %
Shionogi & Co., Ltd. - Financial and Strategic Analysis Review	June 2009	£80	23.5 %
H Lundbeck Deals Partneringdesk briefing	July 2005	£215	23.5 %
AAIPharma Inc. - Strategic Analysis Review	July 2009	£80	23.5 %
ISTA Pharmaceuticals, Inc. - Strategic Analysis Review	March 2009	£80	23.5 %
Mission Pharmacal Company - Strategic Analysis Review	June 2009	£80	23.5 %
Kinray, Inc. - Strategic Analysis Review	July 2009	£80	23.5 %
Serono SA Deals Partneringdesk briefing	July 2005	£215	23.5 %
CSL Ltd - Financial and Strategic Analysis Review	April 2009	£80	23.5 %
Pharmaceutical Management Team, The The Roles, Responsibilities, and Leadership Strategies of CEOs, CTOs, Marketing Executives, and HR Leaders	March 2006	£32	23.45 %
Nycomed International Management GmbH - Strategic Analysis Review	July 2009	£80	23 %
Savient Pharmaceuticals, Inc. - Financial and Strategic Analysis Review	June 2009	£80	23 %
Developing Managed Care Pull-Through Excellence	October 2009	£3310	23 %
Aradigm Corporation - Financial and Strategic Analysis Review	June 2009	£80	23 %
H Lundbeck AS - Financial and Strategic Analysis Review	June 2009	£80	23 %
Schwarz Pharma AG - Financial and Strategic Analysis Review	July 2009	£80	23 %
MediciNova, Inc. - Financial and Strategic Analysis Review	June 2009	£80	23 %
Mitsubishi Pharma Corporation Deals Partneringdesk briefing	July 2005	£215	23 %
Arana Therapeutics Limited - Financial and Strategic Analysis Review	April 2009	£80	23 %
LifeCycle Pharma A/S - Financial and Strategic Analysis Review	June 2009	£80	23 %
ISTA Pharmaceuticals, Inc. - Financial and Strategic Analysis Review	June 2009	£80	23 %
Meldex International PLC - Financial and Strategic Analysis Review	April 2009	£80	23 %
Purdue Pharma LP Deals Partneringdesk briefing	July 2005	£215	23 %
BioDelivery Sciences International, Inc. - Financial and Strategic Analysis Review	June 2009	£80	23 %
MDRNA, Inc. - Financial and Strategic Analysis Review	June 2009	£80	23 %
Exelixis, Inc. - Financial and Strategic Analysis Review	June 2009	£80	23 %
BioSante Pharmaceuticals, Inc. - Financial and Strategic Analysis Review	June 2009	£80	23 %
Quintiles Transnational Corp. - Strategic Analysis Review	July 2009	£80	23 %
Salix Pharmaceuticals, Ltd. - Financial and Strategic Analysis Review	June 2009	£80	23 %
Cougar Biotechnology, Inc. - Financial and Strategic Analysis Review	June 2009	£80	23 %
Understanding the Global Pharmaceutical Market	November 2008	£315	22.75 %
Uzbekistan Pharmaceuticals and Healthcare Report Q1 2010	November 2009	£250	22.75 %
DUSA Pharmaceuticals, Inc - Financial and Strategic Analysis Review	June 2009	£80	22.5 %
VIVUS, Inc. - Financial and Strategic Analysis Review	June 2009	£80	22.5 %
SuperGen, Inc. - Financial and Strategic Analysis Review	June 2009	£80	22.5 %
Santarus, Inc. - Financial and Strategic Analysis Review	June 2009	£80	22.5 %
EntreMed, Inc. - Financial and Strategic Analysis Review	June 2009	£80	22.5 %
Agenix ltd. - Financial and Strategic Analysis Review	April 2009	£80	22.5 %
ViroPharma Incorporated - Financial and Strategic Analysis Review	June 2009	£80	22.5 %
Alexza Pharmaceuticals, Inc. - Financial and Strategic Analysis Review	June 2009	£80	22.5 %
Omnicare, Inc. - Financial and Strategic Analysis Review	June 2009	£80	22.5 %
LifeCycle Pharma AS - Financial and Strategic Analysis Review	April 2009	£80	22.5 %
Celesio AG - Financial and Strategic Analysis Review	June 2009	£80	22.5 %
Genta Incorporated - Financial and Strategic Analysis Review	June 2009	£80	22.5 %
Labopharm Inc. - Financial and Strategic Analysis Review	June 2009	£80	22.5 %
Cardinal Health, Inc. - Financial and Strategic Analysis Review	June 2009	£80	22.5 %
Pharmaceuticals in India	March 2009	£132	22.4 %
Latin American Market for Generic Drugs; The	April 2006	£995	22.05 %
Anadys Pharmaceuticals, Inc - Financial and Strategic Analysis Review	June 2009	£80	22 %
Nippon Kayaku Co., Ltd. - Financial and Strategic Analysis Review	April 2009	£80	22 %
Boiron SA - Financial and Strategic Analysis Review	June 2009	£80	22 %
Auxilium Pharmaceuticals, Inc. - Financial and Strategic Analysis Review	June 2009	£80	22 %
bioMerieux S.A. - Financial and Strategic Analysis Review	June 2009	£80	22 %
Averion International Corp. - Financial and Strategic Analysis Review	June 2009	£80	22 %
Manhattan Pharmaceuticals, Inc. - Financial and Strategic Analysis Review	June 2009	£80	22 %
Cyanotech Corporation - Financial and Strategic Analysis Review	April 2009	£80	22 %
Cypress Bioscience, Inc - Financial and Strategic Analysis Review	June 2009	£80	22 %
Chelsea Therapeutics International, Ltd. - Financial and Strategic Analysis Review	June 2009	£80	22 %
UCB Group - Financial and Strategic Analysis Review	April 2009	£80	22 %
AVANIR Pharmaceuticals - Financial and Strategic Analysis Review	April 2009	£80	22 %
Ipsen S.A. - Financial and Strategic Analysis Review	June 2009	£80	22 %
Novo Nordisk AS - Financial and Strategic Analysis Review	April 2009	£80	22 %
Athersys, Inc. - Financial and Strategic Analysis Review	June 2009	£80	22 %
Caliper Life Sciences Inc. - Financial and Strategic Analysis Review	June 2009	£80	22 %
Endo Pharmaceuticals Holdings Inc. - Financial and Strategic Analysis Review	June 2009	£80	22 %
Merck & Co Inc Deals Partneringdesk briefing	July 2005	£215	22 %
Boehringer Ingelheim GmbH Deals Partneringdesk briefing	July 2005	£215	22 %
3SBio Inc. - Financial and Strategic Analysis Review	June 2009	£80	22 %
Managed Markets Account Management Assessing the Performance of Account Executives	October 2009	£2680	22 %
Vectura Group plc - Financial and Strategic Analysis Review	June 2009	£80	22 %
United Drug plc - Financial and Strategic Analysis Review	June 2009	£80	22 %
Novo Nordisk A/S - Financial and Strategic Analysis Review	June 2009	£80	22 %
Allergy Therapeutics plc - Financial and Strategic Analysis Review	April 2009	£80	22 %
ALK-Abello AS - Financial and Strategic Analysis Review	June 2009	£80	22 %
Acrux Limited - Financial and Strategic Analysis Review	June 2009	£80	22 %
Albany Molecular Research, Inc. - Financial and Strategic Analysis Review	June 2009	£80	22 %
Puerto Rico Pharmaceuticals and Healthcare Report Q3 2008	September 2008	£425	21.7 %
Colombia Pharmaceuticals and Healthcare Report Q3 2008	September 2008	£425	21.7 %
Puerto Rico Pharmaceuticals and Healthcare Report Q4 2008	November 2008	£250	21.7 %
Monitoring and Ensuring Pharmaceutical Compliance	March 2008	£4900	21.5 %
Best Practices for Internal Communications Regarding Brands & Disease States	July 2009	£4710	21.5 %
Alcon, Inc. - Financial and Strategic Analysis Review	June 2009	£80	21.5 %
Acusphere, Inc. - Financial and Strategic Analysis Review	April 2009	£80	21.5 %
Alpha Innotech Corp. - Financial and Strategic Analysis Review	June 2009	£80	21.5 %
EpiCept Corporation - Financial and Strategic Analysis Review	June 2009	£80	21.5 %
Minrad International, Inc. - Financial and Strategic Analysis Review	April 2009	£80	21.5 %
Hospira, Inc. - Financial and Strategic Analysis Review	July 2009	£80	21.5 %
Zila, Inc. - Financial and Strategic Analysis Review	June 2009	£80	21.5 %
eResearchTechnology, Inc. - Financial and Strategic Analysis Review	June 2009	£80	21.5 %
Astellas Pharma Inc. - Financial and Strategic Analysis Review	July 2009	£80	21.5 %
Allergan, Inc. - Financial and Strategic Analysis Review	June 2009	£80	21.5 %
Sepracor Inc. - Financial and Strategic Analysis Review	June 2009	£80	21.5 %
Inspire Pharmaceuticals, Inc. - Financial and Strategic Analysis Review	June 2009	£80	21.5 %
Javelin Pharmaceuticals, Inc. - Financial and Strategic Analysis Review	June 2009	£80	21.5 %
Qiagen N.V. - Financial and Strategic Analysis Review	June 2009	£80	21.5 %
Favrille, Inc. - Financial and Strategic Analysis Review	April 2009	£80	21.5 %
Evotec Aktiengesellschaft - Financial and Strategic Analysis Review	July 2009	£80	21.5 %
Virbac Corporation - Financial and Strategic Analysis Review	April 2009	£80	21.5 %
Jazz Pharmaceuticals, Inc. - Financial and Strategic Analysis Review	June 2009	£80	21.5 %
Sciele Pharma, Inc. - Financial and Strategic Analysis Review	April 2009	£80	21.5 %
OPG Groep - Financial and Strategic Analysis Review	July 2009	£80	21.5 %
Nabi Biopharmaceuticals - Financial and Strategic Analysis Review	June 2009	£80	21.5 %
Meiji Seika Kaisha, Ltd. - Financial and Strategic Analysis Review	April 2009	£80	21.5 %
Forest Laboratories, Inc. - Financial and Strategic Analysis Review	April 2009	£80	21.5 %
GTC Biotherapeutics, Inc. - Financial and Strategic Analysis Review	June 2009	£80	21.5 %
Yakult Honsha Co., Ltd. - Financial and Strategic Analysis Review	July 2009	£80	21.5 %
Helix BioMedix, Inc. - Financial and Strategic Analysis Review	June 2009	£80	21.5 %
Italy Pharmaceuticals and Healthcare Report Q3 2008	September 2008	£425	21.35 %
Managing Process Complexity in the Pharmaceutical Industry with PLM (Strategy Focus)	August 2007	£1000	21.35 %
China Pharmaceutical Industry: Analysis and Market Trends	January 2009	£255	21.35 %
Algeria Pharmaceuticals and Healthcare Report Q4 2008	November 2008	£250	21.35 %
Dainippon Sumitomo Pharma Co., Ltd. - Financial and Strategic Analysis Review	July 2009	£80	21 %
Denmark Generics Market Intelligence Report	March 2006	£295	21 %
Schering-Plough Corporation - Financial and Strategic Analysis Review	April 2009	£80	21 %
King Pharmaceuticals, Inc. - Financial and Strategic Analysis Review	June 2009	£80	21 %
Morocco Pharmaceuticals and Healthcare Report Q4 2008	November 2008	£250	21 %
Pall Corporation - Financial and Strategic Analysis Review	April 2009	£80	21 %
Singaporean Pharmaceuticals and Life Sciences IT Market	December 2008	£5090	21 %
Israel Pharmaceuticals and Healthcare Report Q3 2008 --Israel	July 2008	£425	21 %
The Pharmaceutical Market: Lithuania	June 2009	£595	21 %
Avexa Limited - Financial and Strategic Analysis Review	July 2009	£80	21 %
STERIS Corporation - Financial and Strategic Analysis Review	June 2009	£80	21 %
Indevus Pharmaceuticals, Inc. - Financial and Strategic Analysis Review	April 2009	£80	21 %
Angiotech Pharmaceuticals, Inc. - Financial and Strategic Analysis Review	June 2009	£80	21 %
Matrixx Initiatives, Inc. - Financial and Strategic Analysis Review	July 2009	£80	21 %
Sawai Pharmaceuticals Generics Company Intelligence Report Company Intelligence Report	March 2009	£195	21 %
etrials Worldwide, Inc. - Financial and Strategic Analysis Review	June 2009	£80	21 %
Supply chain management in pharmaceutical industry in Poland 2008	September 2008	£1030	20.65 %
The Pharmaceutical Market: Philippines	June 2009	£595	20.65 %
Switzerland Pharmaceuticals and Healthcare Report Q3 2008	September 2008	£425	20.65 %
Saudi Arabia Pharmaceuticals and Healthcare Report Q3 2008	July 2008	£425	20.65 %
Chile Pharmaceuticals and Healthcare Report Q3 2008	July 2008	£425	20.65 %
The Pharmaceutical Market: Ireland	June 2009	£595	20.65 %
The Pharmaceutical Market: Czech Republic	June 2009	£595	20.65 %
Latvia Pharmaceuticals and Healthcare Report Q3 2008	September 2008	£425	20.65 %
The Pharmaceutical Market: USA	June 2009	£595	20.65 %
Peru Pharmaceuticals and Healthcare Report Q3 2008	September 2008	£425	20.65 %
Pakistan Pharmaceuticals and Healthcare Report Q3 2008	September 2008	£425	20.65 %
Chemicals in South Africa	December 2008	£132	20.5 %
Asahi Kasei Corporation - Financial and Strategic Analysis Review	July 2009	£80	20.5 %
The Pharmaceutical Market: Netherlands Pharmaceuticals, Country Overviews and Healthcare	June 2009	£595	20.3 %
Venezuela Pharmaceuticals and Healthcare Report Q3 2008	September 2008	£425	20.3 %
Poland Pharmaceuticals and Healthcare Report Q3 2008	July 2008	£425	20.3 %
Zimbabwe Pharmaceuticals and Healthcare Report Q3 2008	September 2008	£425	20.3 %
Thailand Pharmaceuticals and Healthcare Report Q3 2008	September 2008	£425	20.3 %
United Kingdom Pharmaceuticals and Healthcare Report Q3 2008	September 2008	£425	20.3 %
The Pharmaceutical Market: Ukraine	June 2009	£595	20.3 %
Chemicals in Canada	December 2008	£132	20 %
Chemicals in Brazil	December 2008	£132	20 %
Chemicals in the United States	December 2008	£132	20 %
Chemicals in Mexico	December 2008	£132	20 %
The Pharmaceutical Market: Singapore	June 2009	£595	19.95 %
The Pharmaceutical Market: Thailand	June 2009	£595	19.95 %
The Pharmaceutical Market: Portugal Pharmaceuticals, Country Overviews and Healthcare	June 2009	£595	19.95 %
Czech Republic Pharmaceuticals and Healthcare Report Q3 2008	July 2008	£425	19.95 %
The Pharmaceutical Market: Indonesia	June 2009	£595	19.95 %
The Pharmaceutical Market: Canada	June 2009	£595	19.95 %
The Pharmaceutical Market: Bulgaria	June 2009	£595	19.95 %
Oman Pharmaceuticals and Healthcare Report Q4 2008	November 2008	£250	19.95 %
The Pharmaceutical Market: Poland	June 2009	£595	19.95 %
The Pharmaceutical Market: Germany	June 2009	£595	19.95 %
Greece Pharmaceuticals and Healthcare Report Q3 2008	September 2008	£425	19.95 %
The Pharmaceutical Market: Japan	June 2009	£595	19.95 %
The Pharmaceutical Market: Malaysia	June 2009	£595	19.95 %
The Pharmaceutical Market: Italy	June 2009	£595	19.95 %
The Pharmaceutical Market: Vietnam	June 2009	£595	19.95 %
The Pharmaceutical Market: Switzerland	June 2009	£595	19.95 %
The Pharmaceutical Market: Colombia	June 2009	£595	19.6 %
The Pharmaceutical Market: Belgium	June 2009	£595	19.6 %
The Pharmaceutical Market: Sweden	June 2009	£595	19.6 %
Slovakia Pharmaceuticals and Healthcare Report Q4 2008	November 2008	£250	19.6 %
Indian Pharmaceutical Market, The Challenges & Opportunities	June 2009	£595	19.6 %
The Pharmaceutical Market: Argentina	June 2009	£595	19.6 %
The Pharmaceutical Market: Morocco	June 2009	£595	19.6 %
Croatia Pharmaceuticals and Healthcare Report Q3 2008	July 2008	£425	19.6 %
The Pharmaceutical Market: Saudi Arabia	June 2009	£595	19.6 %
The Pharmaceutical Market: Slovakia Pharmaceuticals, Country Overviews and Healthcare	June 2009	£595	19.6 %
The Pharmaceutical Market: Finland	June 2009	£595	19.6 %
Moldova Pharmaceuticals and Healthcare Report Q1 2010	November 2009	£250	19.6 %
China Pharmaceuticals and Healthcare Report Q4 2008	November 2008	£250	19.6 %
The Pharmaceutical Market: Mexico	June 2009	£595	19.6 %
OTC Pharmaceuticals in South Korea	February 2009	£132	19.6 %
The Pharmaceutical Market: South Korea Pharmaceuticals, Country Overviews and Healthcare	June 2009	£595	19.6 %
The Pharmaceutical Market: France	June 2009	£595	19.6 %
The Pharmaceutical Market: UK	June 2009	£595	19.6 %
The Pharmaceutical Market: Venezuela	June 2009	£595	19.6 %
The Pharmaceutical Market: Russia	June 2009	£595	19.6 %
China Pharmaceuticals and Healthcare Report Q3 2008	September 2008	£425	19.6 %
Global Generics	August 2007	£125	19.6 %
Mexico Pharmaceuticals and Healthcare Report Q3 2008	July 2008	£425	19.6 %
Chemicals in Singapore	December 2008	£132	19.5 %
Chemicals in Poland	December 2008	£132	19.5 %
Competitive Intelligence Policies, Ethics and Data Collection Navigating The Gray Zone	November 2008	£3545	19.5 %
Chemicals in Asia-Pacific	December 2008	£132	19.5 %
Chemicals in Sweden	December 2008	£132	19.5 %
Chemicals in South Korea	December 2008	£132	19.5 %
UCB Pharma Deals Partneringdesk briefing	July 2005	£215	19.5 %
Chemicals in Taiwan	December 2008	£132	19.5 %
Chemicals in Hungary	December 2008	£132	19.5 %
Chemicals in Australia	December 2008	£132	19.5 %
Chemicals in India	December 2008	£132	19.5 %
Chemicals in China	December 2008	£132	19.5 %
Alcon Inc Deals Partneringdesk briefing	July 2005	£215	19.5 %
Peru Pharmaceuticals and Healthcare Report Q4 2008	November 2008	£250	19.25 %
Bahrain Pharmaceuticals and Healthcare Report Q3 2008	September 2008	£425	19.25 %
Generics in Europe	August 2007	£125	19.25 %
Drug Delivery Markets, Vol. IV: Transdermal	April 2007	£1590	19.25 %
Colombia Pharmaceuticals and Healthcare Report Q1 2009	February 2009	£250	19.25 %
Argentina Pharmaceuticals and Healthcare Report Q3 2008	July 2008	£425	19.25 %
Estonia Pharmaceuticals and Healthcare Report Q3 2008	September 2008	£425	19.25 %
Drug Delivery Markets, Vol III Pulmonary Delivery Systems	March 2007	£1590	19.25 %
Chinese Markets for Pharmaceutical Packaging	June 2009	£2440	19.25 %
Chemicals in the United Kingdom	December 2008	£132	19 %
Chemicals in the Netherlands	December 2008	£132	19 %
Chemicals in Belgium	December 2008	£132	19 %
Chemicals in Denmark	December 2008	£132	19 %
Shionogi & Co Ltd Deals Partneringdesk briefing	July 2005	£215	19 %
Gilead Sciences Inc Deals Partneringdesk briefing	July 2005	£215	19 %
Chemicals in France	December 2008	£132	19 %
Amgen Inc Deals Partneringdesk briefing	July 2005	£215	19 %
Barr Pharmaceuticals Inc Deals Partneringdesk briefing	July 2005	£215	19 %
AstraZeneca Deals Partneringdesk briefing	July 2005	£215	19 %
Tanabe Seiyaku Co Ltd Deals Partneringdesk briefing	July 2005	£215	19 %
Chemicals in Germany	December 2008	£132	19 %
Chemicals in the Czech Republic	December 2008	£132	19 %
Chemicals in Japan	December 2008	£132	19 %
Allergan Inc Deals Partneringdesk briefing	July 2005	£215	19 %
Sankyo Co Ltd Deals Partneringdesk briefing	July 2005	£215	19 %
Novo Nordisk A/S Deals Partneringdesk briefing	July 2005	£215	19 %
Chemicals in Spain	December 2008	£132	19 %
Chemicals in Italy	December 2008	£132	19 %
Chemicals in Norway	December 2008	£132	19 %
Chemicals in Russia	December 2008	£132	19 %
Forest Laboratories Inc Deals Partneringdesk briefing	July 2005	£215	19 %
Generics in the Netherlands	August 2007	£125	18.9 %
Japan Generics Market Intelligence Report	October 2006	£295	18.9 %
Generics in France	August 2007	£125	18.9 %
Generics in Canada	August 2007	£125	18.9 %
Par Pharmaceutical Generics Company Intelligence Report Company Intelligence Report	March 2009	£195	18.9 %
Kuwait Pharmaceuticals and Healthcare Report Q3 2008	July 2008	£425	18.9 %
Pharmaceutical market in Romania 2008 Development forecasts for 2008-2010	October 2008	£1100	18.9 %
Netherlands Pharmaceuticals and Healthcare Report Q4 2008	October 2008	£425	18.9 %
Hong Kong Pharmaceuticals and Healthcare Report Q3 2008	September 2008	£425	18.9 %
Moldova Pharmaceuticals and Healthcare Report Q1 2009	February 2009	£250	18.9 %
Iran Pharmaceuticals and Healthcare Report Q3 2008	September 2008	£425	18.9 %
France Pharmaceuticals and Healthcare Report Q3 2008	September 2008	£425	18.9 %
Serbia Pharmaceuticals and Healthcare Report Q4 2008	November 2008	£250	18.9 %
Russia Pharmaceuticals and Healthcare Report Q3 2008	September 2008	£425	18.55 %
Switzerland Pharmaceuticals and Healthcare Report Q4 2008	October 2008	£425	18.55 %
Pharmaceutical Competitive Intelligence Expanding The Role and Reach of Ci	July 2008	£4900	18.55 %
Greece Pharmaceuticals and Healthcare Report Q4 2008	November 2008	£250	18.55 %
Puerto Rico Pharmaceuticals and Healthcare Report Q2 2009	May 2009	£250	18.55 %
Generics in Belgium	August 2007	£125	18.55 %
Poland Pharmaceuticals and Healthcare Report Q4 2008	October 2008	£425	18.55 %
Slovenia Pharmaceuticals and Healthcare Report Q4 2008	October 2008	£425	18.55 %
Lithuania Pharmaceuticals and Healthcare Report Q4 2008	October 2008	£425	18.55 %
Malaysia Pharmaceuticals and Healthcare Report Q3 2008	September 2008	£425	18.55 %
Eye Care in South Korea	January 2009	£560	18.55 %
Croatia Pharmaceuticals and Healthcare Report Q4 2008	October 2008	£425	18.55 %
OTC Distribution in Europe - 2007 Exploring New Frontiers	June 2007	£1595	18.5 %
Eli Lilly and Company Deals Partneringdesk briefing	July 2005	£215	18.5 %
Bayer AG Deals Partneringdesk briefing	July 2005	£215	18.5 %
Mylan Laboratories Inc Deals Partneringdesk briefing	July 2005	£215	18.5 %
Eisai Co Ltd Deals Partneringdesk briefing	July 2005	£215	18.5 %
Altana AG Deals Partneringdesk briefing	July 2005	£215	18.5 %
Molecular Diagnostics Technologies, Markets and Companies	February 2010	£3185	18.5 %
Schering AG Deals Partneringdesk briefing	July 2005	£215	18.5 %
Oman Pharmaceuticals and Healthcare Report Q3 2007	September 2007	£360	18.2 %
Japan Pharmaceuticals and Healthcare Report Q3 2008	September 2008	£425	18.2 %
Wound Treatments in South Korea	January 2009	£560	18.2 %
Nanoparticles	October 2003	£375	18.2 %
Russia Generics Market Intelligence Report	April 2006	£295	18.2 %
United Arab Emirates Pharmaceuticals and Healthcare Report Q4 2008	November 2008	£250	18.2 %
Belgium Pharmaceuticals and Healthcare Report Q3 2008	September 2008	£425	18.2 %
Ukraine Pharmaceuticals and Healthcare Report Q1 2009	May 2009	£250	18.2 %
Belgium Pharmaceuticals and Healthcare Report Q1 2010	November 2009	£250	18.2 %
Brazil Pharmaceuticals and Healthcare Report Q3 2008	September 2008	£425	18.2 %
Vietnam Pharmaceuticals & Healthcare	December 2006	£395	18.2 %
United Arab Emirates Pharmaceuticals and Healthcare Report Q3 2008	September 2008	£425	18.2 %
IVAX Corporation Deals Partneringdesk briefing	July 2005	£215	18 %
Top 100 Best Pharma Outsourcing Service Providers in China and India	July 2009	£600	18 %
Schering-Plough Corporation Deals Partneringdesk briefing	July 2005	£215	18 %
Genzyme Corporation Deals Partneringdesk briefing	July 2005	£215	18 %
Merck KGaA Deals Partneringdesk briefing	July 2005	£215	18 %
Bristol-Myers Squibb Company Deals Partneringdesk briefing	July 2005	£215	18 %
Sanofi-Aventis Deals Partneringdesk briefing	July 2005	£215	18 %
India Pharmaceuticals and Healthcare Report Q3 2008	July 2008	£425	17.85 %
Zentiva Generics Company Intelligence Report Company Intelligence Report	March 2009	£195	17.85 %
Digestive Remedies in South Korea	January 2009	£560	17.85 %
Analgesics in South Korea	January 2009	£560	17.85 %
NRT Smoking Cessation Aids in South Korea	January 2009	£560	17.85 %
Pharmaceuticals in Europe	March 2009	£132	17.85 %
Ukraine Pharmaceuticals & Healthcare	February 2009	£250	17.85 %
Nigeria Pharmaceuticals and Healthcare Report Q4 2008	November 2008	£250	17.85 %
OTC Pharmaceuticals in India	February 2009	£132	17.5 %
Chemicals in Europe	December 2008	£132	17.5 %
Iran Pharmaceuticals and Healthcare Report Q1 2010	November 2009	£250	17.5 %
Pharmaceuticals in Belgium	March 2009	£132	17.5 %
Global Chemicals	December 2008	£132	17.5 %
Eye Care in Taiwan	June 2008	£450	17.5 %
Drug Delivery Markets Oral Delivery	January 2007	£1590	17.5 %
Lebanon Pharmaceuticals and Healthcare Report Q3 2008	September 2008	£425	17.5 %
Croatia Pharmaceuticals and Healthcare Report Q1 2010	November 2009	£250	17.5 %
Eye Care in Israel	July 2008	£450	17.5 %
Wound Treatments in Taiwan	June 2008	£450	17.5 %
Qatar Pharmaceuticals and Healthcare Report Q1 2009	February 2009	£250	17.5 %
Wound Treatments in Israel	July 2008	£450	17.5 %
Chugai Pharmaceutical Co. Ltd: PharmaVitae Profile	March 2009	£3010	17.5 %
RFID in Pharmaceutical Manufacturing Cost Saving Strategies for Pharmaceutical Companies and Opportunities for Technology Companies	March 2008	£1270	17.5 %
Spain Pharmaceuticals and Healthcare Report Q2 2009	April 2009	£250	17.15 %
Chile Pharmaceuticals and Healthcare Report Q2 2009	April 2009	£250	17.15 %
Vitamins and Dietary Supplements in South Korea	January 2009	£560	17.15 %
Nigeria Pharmaceuticals and Healthcare Report Q3 2007	September 2007	£360	17.15 %
Digestive Remedies in Israel	July 2008	£450	17.15 %
Medicated Skin Care in South Korea	January 2009	£560	17.15 %
Czech Republic Generics Market Intelligence Report	January 2006	£295	17.15 %
Lebanon Pharmaceuticals and Healthcare Report Q4 2008	November 2008	£250	17.15 %
Analgesics in Israel	July 2008	£450	17.15 %
Indonesia Pharmaceuticals and Healthcare Report Q3 2006	February 2009	£250	17.15 %
Analgesics in Taiwan	June 2008	£450	17.15 %
Digestive Remedies in Taiwan	June 2008	£450	17.15 %
Pakistan Pharmaceuticals and Healthcare Report Q1 2009	January 2009	£250	17.15 %
Streamlining Information in the Pharmaceutical Industry with PLM (Review Report)	August 2007	£1795	17.15 %
Pharmaceutical Markets in India	April 2004	£825	17.15 %
Pfizer Inc Deals Partneringdesk briefing	July 2005	£215	17 %
The Top 100 Drug Delivery Companies Worldwide	January 2004	£555	17 %
Singapore Pharmaceuticals and Healthcare Report Q4 2008	November 2008	£250	16.8 %
Eye Care in Egypt	September 2008	£560	16.8 %
Wound Treatments in Egypt	September 2008	£560	16.8 %
Analgesics in Egypt	September 2008	£560	16.8 %
Smoking Cessation Aids in Japan	October 2005	£450	16.8 %
Taiwan Pharmaceuticals and Healthcare Report Q3 2007	February 2009	£250	16.8 %
UK Pharmaceutical Products Market Development Report	September 2005	£600	16.8 %
Generics in Italy	August 2007	£125	16.8 %
Generics in China	August 2007	£125	16.8 %
Switzerland Pharmaceuticals and Healthcare Report Q1 2009	January 2009	£250	16.8 %
Drug Delivery Markets, Vol II Implantable Injectable	February 2007	£1590	16.8 %
Medicated Skin Care in Russia	November 2007	£450	16.8 %
South Korea Pharmaceuticals and Healthcare Report Q3 2007	May 2009	£250	16.8 %
Cough, Cold and Allergy (Hay Fever) Remedies in South Korea	January 2009	£560	16.8 %
Vitamins and Dietary Supplements in Taiwan	June 2008	£450	16.8 %
NRT Smoking Cessation Aids in Taiwan	June 2008	£450	16.8 %
NRT Smoking Cessation Aids in Israel	July 2008	£450	16.8 %
Bahrain Pharmaceuticals and Healthcare Report Q2 2009	May 2009	£250	16.8 %
Partneringdesk deals and alliances in genitourinary and gynecological diseases	April 2006	£1250	16.5 %
Partneringdesk deals and alliances in metabolic diseases	April 2006	£1250	16.5 %
Partneringdesk deals and alliances in gastrointestinal diseases	April 2006	£1250	16.5 %
Taiwan Pharmaceuticals and Healthcare Report Q2 2009	April 2009	£250	16.45 %
Digestive Remedies in Egypt	September 2008	£560	16.45 %
Menarini: PharmaVitae Profile	March 2009	£3010	16.45 %
Medicated Skin Care in Sweden	October 2007	£450	16.45 %
Medicated Skin Care in Japan	September 2007	£450	16.45 %
NRT Smoking Cessation Aids in Japan	June 2006	£450	16.45 %
Hungary Pharmaceuticals and Healthcare Report Q3 2008	September 2008	£425	16.45 %
Philippines Pharmaceuticals Report Q1 2007	April 2007	£395	16.45 %
Vitamins And Dietary Supplements in Israel	July 2008	£450	16.45 %
Eye Care in Japan	September 2007	£450	16.45 %
United Arab Emirates Pharmaceuticals and Healthcare Report Q2 2009	April 2009	£250	16.45 %
Latin American Developing Markets for Pharmaceuticals, 2006-2011	November 2006	£1999	16.45 %
Medicated Skin Care in Israel	July 2008	£450	16.45 %
Serbia Pharmaceuticals and Healthcare Report Q1 2009	January 2009	£250	16.45 %
Czech Republic Pharmaceuticals and Healthcare Report Q1 2009	February 2009	£250	16.45 %
Drug Delivery Markets: Implantable / Injectable and Needle-Free Delivery Systems	September 2009	£1905	16.1 %
Romania Pharmaceuticals and Healthcare Report Q3 2007	February 2009	£250	16.1 %
Switzerland Generics Market Intelligence Report	May 2006	£295	16.1 %
United States Pharmaceuticals and Healthcare Report Q4 2008	November 2008	£250	16.1 %
An Overview of the South African Healthcare Industry	December 2008	£4775	16.1 %
Cough, Cold and Allergy (Hay Fever) Remedies in Israel	July 2008	£450	16.1 %
Vitamins And Dietary Supplements in Egypt	September 2008	£560	16.1 %
GlaxoSmithKline plc: PharmaVitae Profile	October 2010	£5700	16.1 %
Cough, Cold and Allergy (Hay Fever) Remedies in Taiwan	June 2008	£450	16.1 %
Medicated Skin Care in Egypt	September 2008	£560	16.1 %
Japan Pharmaceuticals and Healthcare Report Q1 2009	March 2009	£250	16.1 %
Pharmaceuticals in South Korea	March 2009	£132	16.1 %
Clinical Outsourcing Strategy Selecting Partners and Managing Relationships	May 2009	£4900	16 %
The Scandinavian Pharmaceutical Market Outlook to 2013 Policy environment, market structure, pipeline analysis, growth opportunities	March 2009	£2025	15.75 %
Wound Treatments in Vietnam	April 2009	£560	15.75 %
The Future of the Pharmaceutical Packaging Industry Emerging Economies Poised to Capitalize on Increasing Demand	December 2009	£2230	15.75 %
Wound Treatments in Brazil	August 2007	£450	15.75 %
Germany Pharmaceuticals and Healthcare Report Q2 2009	April 2009	£250	15.75 %
OTC Pharmaceuticals in Asia-Pacific	February 2009	£132	15.75 %
Eye Care in Vietnam	April 2009	£560	15.75 %
OTC Pharmaceuticals in China	February 2009	£132	15.75 %
Medicated Skin Care in Portugal	January 2008	£450	15.75 %
Canada Pharmaceuticals and Healthcare Report Q3 2007	January 2009	£250	15.75 %
Pharmaceuticals in China	February 2006	£3055	15.75 %
Analytical Tool: Lymphoma Therapeutics & Competitive Insights	January 2010	£2705	15.5 %
Triple Analysis: Protein Kinase Inhibitors, Antibodies and Vaccines in Oncology	August 2006	£3010	15.5 %
Analytical Tool - Melanoma	January 2009	£2705	15.5 %
Egypt Pharmaceuticals & Healthcare	May 2009	£250	15.4 %
Major Pharmaceutical Markets of the Middle East An overview of Egypt, Israel, Jordan, Lebanon, Saudi Arabia & UAE (2nd Ed)	February 2009	£1295	15.4 %
Asia Generic Pharmaceuticals Forecast Report; The	July 2006	£510	15.4 %
Health Care Equipment & Supplies in China	July 2008	£180	15.4 %
Pharmaceuticals in Japan	March 2009	£132	15.4 %
Cough, Cold and Allergy (hay Fever) Remedies in Egypt	September 2008	£560	15.4 %
World Pharmaceutical Packaging Forecasts For 2011 & 2016 For 18 Countries	July 2007	£3690	15.4 %
Rx market in Poland 2006 Development forecasts 2006-2008	November 2006	£1350	15.4 %
Digestive Remedies in Vietnam	April 2009	£560	15.4 %
Analgesics in Vietnam	April 2009	£560	15.4 %
Drug Delivery in Asia-Pacific	October 2006	£105	15.4 %
The Turkish Pharmaceutical Market Outlook to 2014 Policy environment, market structure, competitive landscape, growth opportunities	January 2010	£3835	15.4 %
India Pharmaceuticals and Healthcare Report Q1 2009	February 2009	£250	15.4 %
Dainippon Sumitomo: Pipeline, Products, Performance, Potential	November 2007	£595	15.05 %
Indian Bulk Drug Industry Insight 2007	May 2007	£400	15.05 %
Pharmaceutical Branding Strategies Thought leader perspectives on brand building, effective communication and future brand models	January 2006	£1495	15.05 %
Drug Delivery Series I-IV	April 2007	£4550	15.05 %
Venezuela Pharmaceuticals and Healthcare Report Q2 2009	May 2009	£250	15.05 %
Analytical Tool - Prostate Cancer A Therapeutic & Competitive Insight	January 2009	£2705	15 %
Analytical Tool - Cancer Vaccines	January 2009	£2705	15 %
Triple Analysis: Melanoma Therapeutics, Antibodies and Vaccines in Oncology	August 2006	£3010	15 %
Bariatric (Obesity) Care Equipment & Surgical Devices Worldwide A Market Strategy Report	February 2006	£1270	15 %
Pharma R&D Fact Book, The 2006	November 2007	£495	15 %
Medicated Skin Care in Vietnam	April 2009	£560	14.7 %
Vitamins and Dietary Supplements in Vietnam	April 2009	£560	14.7 %
AstraZeneca plc: PharmaVitae Profile	September 2009	£5700	14.7 %
Johnson & Johnson Performance, Capabilities, Goals and Strategies in The Worldwide Pharmaceutical Market	September 2009	£1210	14.7 %
Drug Delivery in Japan	October 2006	£105	14.7 %
Business Blogging for Pharma	August 2007	£2005	14.7 %
South Africa Pharmaceuticals and Healthcare Report Q3 2008	June 2008	£425	14.7 %
Les Laboratoires Servier: PharmaVitae Profile	October 2008	£3010	14.7 %
Wound Treatments in Sweden	October 2007	£450	14.7 %
Australia Pharmaceuticals & Healthcare	February 2009	£250	14.7 %
Pharmaceutical Market Trends, 2008 - 2012 Key market forecasts and growth opportunities (3rd Edition)	November 2008	£1350	14.7 %
Currently Druggable in Breast Cancer A Drug Target Competitive Analysis	August 2008	£1700	14.5 %
Analytical Tool - Cancer Therapeutic Antibodies	January 2009	£3580	14.5 %
Analytical Tool - Protein Kinase Inhibitors in Oncology	January 2009	£2705	14.5 %
Guide to Pharmaceutical Outsourcing in China	February 2008	£625	14.35 %
Pfizer Inc.: PharmaVitae Profile	July 2009	£5700	14.35 %
Pharmaceutical Supply Chain Strategies Reassessing Product Distribution to Cut Costs and Improve Supply Chain Management	March 2008	£2005	14.35 %
Cough, Cold and Allergy (Hay Fever) Remedies in Vietnam	April 2009	£560	14.35 %
Wound Treatments in Thailand	November 2007	£450	14.35 %
Dr Reddy's Laboratories Generics Company Intelligence Report	June 2008	£195	14.35 %
Central and Eastern European (CEE) Developing Markets for Pharmaceuticals, 2006-2011	November 2006	£1999	14.35 %
Astellas: PharmaVitae Profile	February 2007	£1060	14.35 %
Dr Reddy's Laboratories Generics Company Intelligence Report	June 2008	£195	14.35 %
Strategic Alliances in World Pharma and Biotech Markets	November 2008	£315	14.35 %
Eprescribing Infrastructure and Impact on the Healthcare Markets in the US and EU	March 2007	£2005	14.35 %
Malaysia: Country Scan Country Scan	August 2006	£550	14 %
Reaching Doctors and Patients Through New Digital Media	January 2008	£2005	14 %
Winning Pharmaceutical Brand Management Maximizing brand value through best practice in brand development and product marketing	March 2006	£1495	14 %
Pharmaceutical Markets in Brazil, Russia, India and China (Bric Nations)	July 2008	£1125	14 %
Nycomed A/S: PharmaVitae Profile	March 2009	£3010	14 %
Healthcare and Pharmaceuticals in Latin America A guide to the markets and regulations	May 2005	£525	14 %
Eye Care in Slovakia	July 2006	£450	14 %
UCB S.A.: PharmaVitae Profile	March 2009	£3010	14 %
Global Bulk Drugs Industry Report	August 2006	£550	14 %
Eli Lilly & Co.: PharmaVitae Profile	July 2009	£5700	14 %
Wound Treatment in China	December 2005	£450	14 %
Forest Laboratories Inc.: PharmaVitae Profile	November 2008	£3010	14 %
Japanese Pharmaceutical Market, 2006-2011	January 2006	£1499	13.65 %
NRT Smoking Cessation Aids in China	July 2008	£450	13.65 %
Obesity Drug Markets in the US and EU Analysis of product pipelines and the competitive environment	July 2008	£1995	13.65 %
AstraZeneca: Pipeline, Products, Performance, Potential	November 2007	£595	13.65 %
Singapore Pharmaceuticals & Healthcare	January 2007	£395	13.65 %
Wound Treatments in China	July 2008	£450	13.65 %
Wound Treatments in Slovakia	July 2006	£450	13.65 %
Boehringer Ingelheim GmbH: PharmaVitae Profile	March 2009	£3010	13.65 %
Global Life Sciences Tools & Services	March 2007	£110	13.65 %
F. Hoffmann-La Roche Ltd.: PharmaVitae Profile	July 2009	£5700	13.65 %
Celgene Corporation: PharmaVitae Profile Healthcare	March 2009	£3010	13.65 %
Johnson & Johnson: PharmaVitae Profile Healthcare	July 2009	£5700	13.65 %
Bioinformatics Market Potential	January 2009	£315	13.65 %
Analgesics in Saudi Arabia	June 2006	£450	13.65 %
Takeda Pharmaceutical Co. Ltd: PharmaVitae Profile	February 2009	£3010	13.65 %
Bulgaria Pharmaceuticals & Healthcare	December 2006	£395	13.65 %
Analgesics in Slovakia	July 2006	£450	13.65 %
Allergan: Pipeline , Products , Performance , Potential	February 2008	£595	13.65 %
Eye Care in China	July 2008	£450	13.65 %
Novo Nordisk A/S: PharmaVitae Profile	July 2008	£3010	13.3 %
Wound Treatment in South Korea	December 2005	£450	13.3 %
Prescribing Pharmacists A Decision Maker Emerges	September 2007	£1590	13.3 %
Forest Laboratories Pipeline Products Performance Potential	October 2007	£595	13.3 %
Medicated Skin Care in China	July 2008	£450	13.3 %
Cough, Cold and Allergy (Hay Fever) Remedies in Japan	September 2007	£450	13.3 %
The Indian Pharmaceutical Market to 2011 Competitive dynamics and major players	July 2007	£1495	13.3 %
Alcon Inc.: PharmaVitae Profile	March 2009	£3010	13.3 %
Solvay Prospects to 2010 Pipeline, Products,Performance,Potential	December 2008	£595	13.3 %
UCB Prospects to 2010	November 2008	£595	13.3 %
NRT Smoking Cessation Aids in Saudi Arabia	June 2006	£450	13.3 %
Daiichi Sankyo Co., Ltd: PharmaVitae Profile	February 2009	£3010	13.3 %
Indian Pharmaceutical Market, 2006-2011	June 2006	£1499	13.3 %
NRT Smoking Cessation Aids in Slovakia	July 2006	£450	13.3 %
Sepracor Inc.: PharmaVitae Profile	March 2009	£3010	13.3 %
Biogen Idec Inc.: PharmaVitae Profile	March 2009	£3010	13.3 %
Italy Generics Market Intelligence Report	March 2006	£295	13.3 %
Johnson & Johnson: Pharma Growth Strategy How does the world's 7th largest pharma company plan to grow its pharmaceutical revenues?	July 2009	£245	13.3 %
The Japanese Pharmaceutical Market Outlook to 2014 Policy environment, market structure, competitive landscape, growth opportunities	January 2010	£3835	13.3 %
Indian Generics, 2008-2012 A Growing Threat to Westernised Markets	January 2008	£1600	13.3 %
Genentech Inc.: PharmaVitae Profile	March 2009	£3010	13.3 %
Global Pharmaceuticals, Biotechnology & Life Sciences	May 2008	£230	13 %
Pharmaceutical Regulatory Affairs in the EU and US	December 2006	£1095	13 %
How Drugs Are Developed 3rd Edition	January 2007	£1095	13 %
The World OTC Pharmaceutical Market Analysis & Forecasts, 2008-2023	June 2008	£1499	12.95 %
Vitamins and Dietary Supplements in Slovakia	July 2006	£450	12.95 %
King Pharmaceuticals Inc.: PharmaVitae Profile	March 2009	£3010	12.95 %
NRT Smoking Cessation Aids in Brazil	August 2007	£450	12.95 %
Vitamins and Dietary Supplements in Venezuela	February 2008	£450	12.95 %
Cough, Cold and Allergy (Hay Fever) Remedies in Mexico	February 2008	£450	12.95 %
Specialty Pharma Market Outlook, The Key players, new company growth models and emerging opportunities	October 2006	£1495	12.95 %
Digestive Remedies in Slovakia	July 2006	£450	12.95 %
Astellas Pharma Inc.: PharmaVitae Profile	February 2009	£3010	12.95 %
Generic Series: An Introduction to the Canadian Generics Market Key trends and leading companies shaping the market	June 2007	£2005	12.95 %
Pharmaceutical Licensing Strategies Best practices in deal-making, valuations and strategic management	June 2006	£1495	12.95 %
European Point of Care (POC) Infectious Disease Market	December 2008	£3820	12.95 %
Smoking Cessation Aids in South Korea	December 2005	£450	12.95 %
Chinese Markets for Biotechnology	August 2006	£2545	12.95 %
Digestive Remedies in Saudi Arabia	June 2006	£450	12.95 %
Vitamins and Dietary Supplements in China	July 2008	£450	12.95 %
Biotechnological Innovations In The Pharmaceutical Industry in Poland 2009 Development forecasts for biotechnology sector for 2009-2011	August 2009	£1745	12.95 %
Cough, Cold and Allergy (Hay Fever) Remedies in Hong Kong	October 2007	£450	12.95 %
Roche & Genentech: a model for future biotech deals?	August 2009	£175	12.95 %
Vitamins And Dietary Supplements in Saudi Arabia	June 2006	£450	12.6 %
Eye Care in Russia	November 2007	£450	12.6 %
Analyzing the Generic Drugs Sector of the US Pharmaceutical Industry	January 2008	£650	12.6 %
Spain Pharmaceuticals & Healthcare	July 2006	£395	12.6 %
Analgesics in Thailand	July 2008	£450	12.6 %
Wound Treatments in Hong Kong	March 2006	£450	12.6 %
Understanding Chiral Technologies Chiral Technology Revenues Soar to $16.03 Billion	November 2008	£315	12.6 %
Dainippon Sumitomo Pipeline Products Performance Potential	December 2008	£595	12.6 %
Eye Care in Indonesia	April 2009	£560	12.6 %
Cosmeceuticals US industry forecasts for 2012 & 2017	October 2008	£2990	12.6 %
Genzyme Corporation: PharmaVitae Profile	March 2009	£3010	12.6 %
European Generic Drug Market Potential The Emergence of Generic Drug Biologics	February 2009	£380	12.6 %
Eye Care in Thailand	July 2008	£450	12.6 %
Digestive Remedies in Thailand	July 2008	£450	12.6 %
Consolidation in the Generic Pharmaceutical Industry An evolving landscape	October 2007	£1250	12.6 %
OTC market in Poland 2007 Development forecasts 2007-2009	June 2007	£1440	12.6 %
Medicated Skin Care in Slovakia	July 2006	£450	12.6 %
Shire: Pipeline • Products • Performance • Potential	December 2008	£595	12.6 %
Wound Treatments in Argentina	August 2007	£450	12.6 %
Pharmaceutical Outsourcing Strategies Market expansion, offshoring and strategic management in the CRO and CMO marketplace	April 2006	£1495	12.6 %
NRT Smoking Cessation Aids in Chile	July 2007	£450	12.6 %
Wound Treatments in Indonesia	April 2009	£560	12.6 %
Medical Imaging Markets, Volume IV Contrast Agents	February 2007	£1905	12.25 %
Chinese Markets for Antibiotics	April 2009	£2755	12.25 %
Wyeth PharmaVitae Profile	July 2008	£3010	12.25 %
OTC Pharmaceuticals in Taiwan	February 2009	£132	12.25 %
Cough, Cold and Allergy (Hayfever) Remedies in China	December 2005	£450	12.25 %
NRT Smoking Cessation Aids in Thailand	July 2008	£450	12.25 %
Innovations and Trends in Clinical Trials Microdosing (Phase 0 Trials), Adaptive Trials, Phase IV Trials and the Role of Information Technology	March 2007	£1430	12.25 %
Digestive Remedies in Indonesia	April 2009	£560	12.25 %
Wyeth: PharmaVitae Profile PharmaVitae Profile	March 2009	£3010	12.25 %
AstraZeneca Plc PharmaVitae Profile	July 2008	£3010	12.25 %
Bayer Schering Pharma AG: PharmaVitae Profile	July 2009	£5700	12.25 %
Schering-Plough Corporation PharmaVitae Profile	July 2008	£3010	12.25 %
Dr Reddy Generics Company Intelligence Report Company Intelligence Report	March 2009	£195	12.25 %
Amgen Inc.: PharmaVitae Profile Healthcare	July 2009	£5700	12.25 %
200 China-based Best CROs and CMOs	March 2009	£955	12.25 %
RNAi Therapeutics 2008	November 2007	£2350	12.25 %
Turkey Pharmaceuticals & Healthcare	September 2006	£395	12.25 %
A Guide to Drug Pricing and Reimbursement	September 2007	£1525	12.25 %
Shire plc: PharmaVitae Profile	November 2008	£3010	12.25 %
Bristol-Myers Squibb Co.: PharmaVitae Profile	September 2009	£5700	12.25 %
Cough, Cold and Allergy (Hay Fever) Remedies in Slovakia	July 2006	£450	12.25 %
Analgesics in Indonesia	April 2009	£560	12.25 %
Partneringdesk deals and alliances in musculoskeletal diseases	April 2006	£1250	12 %
The Outlook for Emerging Central American Pharmaceutical Markets 2009	January 2009	£795	11.9 %
Germany Generics Market Intelligence Report	August 2006	£295	11.9 %
Abbott Laboratories: PharmaVitae Profile Healthcare	September 2009	£5700	11.9 %
Pharmaceutical Parallel Trade in the United Kingdom, 2000-2006 Market Insights and Trends in a Primary Import Destination	August 2006	£900	11.9 %
Pharmaceutical Pricing, Reimbursement and Parallel Trade 2006	March 2006	£1270	11.9 %
Canadian Pharmaceutical Market Outlook to 2013 olicy environment, market structure, pipeline analysis, growth opportunities	March 2009	£2025	11.9 %
The Pain Market Outlook to 2011	June 2006	£1495	11.9 %
Johnson & Johnson PharmaVitae Profile	July 2008	£3010	11.9 %
Lundbeck Pharmaceutical Company Intelligence Report Performance, Products, Pipeline and Potential	March 2009	£595	11.9 %
Teva Pharmaceutical Industries Generics Company Intelligence Report	June 2008	£195	11.9 %
Medicated Skin Care in Thailand	July 2008	£450	11.9 %
Cough, Cold and Allergy (Hayfever) Remedies in South Korea	December 2005	£450	11.9 %
Medicated Skin Care in Indonesia	April 2009	£560	11.9 %
Pharmaceutical Distribution in the US Current and Future Perspectives	July 2009	£1495	11.9 %
Vitamins and Dietary Supplements in Thailand	July 2008	£450	11.9 %
Eye Care in Norway	October 2007	£450	11.9 %
Vitamins and Dietary Supplements in Hong Kong	October 2007	£450	11.9 %
Drug Development Opportunities In China Regulation, Key Players And Initiatives For Domestic And International Markets	September 2007	£1495	11.9 %
Evaluation of Current Service Capabilities of Chinese Pharmaceutical Outsourcing Service Industry	May 2008	£560	11.9 %
Vitamins and Dietary Supplements in Indonesia	April 2009	£560	11.9 %
Astellas Pharma Performance, Products, Pipeline and Potential	January 2009	£595	11.55 %
Novartis AG: PharmaVitae Profile	July 2009	£5700	11.55 %
Biogenerics, The World Market Biosimilars and Follow-On Biologics at a Crossroads	April 2008	£2230	11.55 %
Emerging Pharmaceutical Markets Argentina and Mexico	March 2008	£3800	11.55 %
China's Attraction and Strategies to Work with It Analysis of Best Strategies for Western Pharmaceutical and Biotech Companies to Partner with Chinese Pharmaceutical Comp	July 2008	£1020	11.55 %
Achieving success in the Developing Asian Pharmaceutical Sector 2007-2011	November 2006	£1999	11.55 %
Analgesics in Denmark	November 2007	£450	11.55 %
Merck KGaA: PharmaVitae Profile	March 2009	£3010	11.55 %
China's Attraction and Strategies to Work with It Analysis of Best Strategies for Western Pharmaceutical and Biotech Companies to Partner with Chinese Pharmaceutical Companies	July 2008	£955	11.55 %
Cough, Cold and Allergy (Hay Fever) Remedies in Indonesia	April 2009	£560	11.55 %
OTC Healthcare in United Arab Emirates	November 2008	£750	11.55 %
Ophthalmic Pharmaceuticals, Market Analysis, Forecasts and Dynamics 2009-2023	January 2009	£1499	11.2 %
Medical Plastics US industry forecasts for 2012 & 2017	February 2009	£2990	11.2 %
NRT Smoking Cessation Aids in India	February 2008	£450	11.2 %
Japanese Pharmaceutical Market 2008-2023, the	October 2008	£1499	11.2 %
Patient Compliance Europe	August 2006	£75	11.2 %
Enzymes US industry forecasts to 2010 & 2015	July 2006	£2735	11.2 %
Nanotechnology in Health Care to 2009	May 2005	£2675	11.2 %
Roche: Pipeline, Products, Performance, Potential	November 2007	£595	11.2 %
eHealth Solutions for Pharma Strategies for salesforces, marketing, patient compliance and clinical trials	March 2007	£1495	11.2 %
Altana Pharmaceutical Company Intelligence Report	August 2006	£795	11.2 %
The Top 40 Manufacturers Of Diagnostic Imaging Equipment In Europe	June 2009	£245	11 %
Wound Treatments in India	August 2006	£450	10.85 %
France Generics Market Intelligence Report 9	February 2006	£295	10.85 %
Biochips Industry forecasts for 2012 & 2017	October 2008	£2930	10.85 %
Actavis Generics Company Intelligence Report Company Intelligence Report	March 2009	£195	10.85 %
Protein Therapeutics Markets (Antithrobins, Cytokines, Growth Hormones, Hematopoietics, Insulin, Monoclonal Antibodies, Plasma Proteins, Vaccines, and Other Treatments)	December 2008	£2225	10.85 %
China’s Guidebook for Pharmaceutical Patent Protection	June 2008	£950	10.85 %
Merck & Co. Inc: PharmaVitae Profile	July 2009	£5700	10.85 %
World OTC Pharmaceutical Markets Self-Medication, Developing and Petro-Rich Economies, BTC and Other Growth Trends	May 2008	£2035	10.85 %
Eye Care in India	February 2008	£450	10.85 %
KRKA Generics Company Intelligence Report Company Intelligence Report	March 2009	£195	10.85 %
Key Players in Pharmaceutical Contract Manufacturing Market developments, outsourcing hotspots and growth strategies	March 2009	£2025	10.85 %
Bringing Drugs to Market The role of CRM in improving sales & marketing (Review Report)	August 2007	£1000	10.85 %
Gastrointestinal Drug Discoveries	January 2008	£995	10.85 %
Pharmaceutical Distribution in Europe The Emergence of Direct-to-Pharmacy Supply	February 2008	£995	10.85 %
Analgesics in India	August 2006	£450	10.85 %
Coagulation Factors 2009 Target Pipeline and Corporate Benchmark Analysis	August 2009	£2140	10.5 %
Bayer Schering Pharma Ag PharmaVitae Profile	July 2008	£3010	10.5 %
Smart Packaging Markets: 2006-2013	April 2006	£1090	10.5 %
Indian Pharmaceuticals Industry Report	December 2009	£600	10.5 %
Mobile and Wireless Sales Force Strategies	April 2006	£75	10.5 %
Indian Medical Market Report 2005	May 2005	£705	10.5 %
Wound Treatment in Taiwan	December 2005	£450	10.5 %
Medicated Skin Care in India	February 2008	£450	10.5 %
Biogen Idec: Pipeline - Products - Performance - Potential	January 2009	£595	10.5 %
Contract Manufacturing Strategies Market developments, technology transfer and key success factors	May 2008	£2325	10.5 %
Ion Channel Drug Discovery Therapeutic Opportunities & Technology Progress	May 2004	£870	10.5 %
World Enzymes Study # 2229	September 2007	£3435	10.5 %
Biogen Idec Pipeline Products Performance Potential	March 2008	£595	10.5 %
Analgesics in Finland	October 2007	£450	10.5 %
Vitamins and Dietary Supplements in India	August 2006	£450	10.5 %
Impact of Counterfeits on Parallel Trade & Pharmaceutical Distribution Issues, initiatives and insights for supply chain integrity	September 2009	£3835	10.15 %
Pharmaceutical Product Relaunch Preserving Market Share through Line Extension and New Market Entry Strategies	April 2007	£4900	10.15 %
World Market for Prescription Generic Drugs 6th Edition	April 2008	£2545	10.15 %
The Global OTC Pharmaceutical Market 2009-2024	May 2009	£1499	10.15 %
Comparison of Pharma Outsourcing between China and India	July 2009	£955	10.15 %
UK Laboratory Equipment Market Development Report	March 2005	£550	10.15 %
OTC Healthcare - Uzbekistan	April 2009	£750	10.15 %
Product Lifecycle Management, 2006	May 2006	£1499	10.15 %
Teva Generics Company Intelligence Report Company Intelligence Report	March 2009	£195	10.15 %
Clinical Trials Market 2006, The	February 2006	£1499	10.15 %
Global Generics Industry Report	September 2006	£550	9.8 %
World Market for Prescription Respiratory Drugs, The	October 2006	£2230	9.8 %
CNS Market Trends, 2007 to 2010 Key Market Forecasts and Growth Opportunities	June 2007	£995	9.8 %
World Market for Psychotherapeutic Drugs, The	January 2007	£2230	9.8 %
Alcon Pipeline,Products,Performance,Potential	December 2008	£595	9.8 %
Cosmetic Surgery Products	September 2006	£2930	9.8 %
Pharmaceutical Outsourcing Opportunities Post Launch Contract Manufacturing, and Sales and Marketing,2nd Edition	September 2006	£2480	9.8 %
Cough, Cold and Allergy (Hay Fever) Remedies in India	February 2008	£450	9.8 %
Chemical Catalysts to 2009	October 2005	£2610	9.8 %
World Market for Pain Management Drugs and Devices 2nd Edition	December 2006	£2230	9.8 %
World Market for Prescription Orthopedic Drugs, The	October 2006	£2230	9.8 %
The Worldwide Market for Cancer Diagnostics 3rd Edition	March 2008	£2545	9.8 %
Stakeholder Opinions: Bone Metastases Impending Patent Expiries May Help Make or Break Newer Agents	March 2008	£2005	9.8 %
Emerging Generic Pharmaceuticals Markets in Europe	December 2008	£3820	9.8 %
Patient Empowerment Empowered Patients Can Change Healthcare Outcomes And Impact The Pharmaceutical Industry	July 2007	£3000	9.8 %
Obesity, Weight Loss and Diet Management Markets Pharmaceutical, Surgical and Dietary Approaches	December 2009	£2230	9.8 %
Companion Diagnostics Markets (A Realistic Assessment of the Opportunities, Challenges, Key Players and Important Trends in Personalized Medicine)	June 2008	£1905	9.8 %
Global Market for Adjunctive Therapies in Cancer, The 2nd Edition	April 2006	£2230	9.8 %
Anti-Aging Products to 2009	June 2005	£2675	9.8 %
World Market for Prescription Gastrointestinal Drugs, The	July 2006	£2230	9.8 %
The Impact of the Phase III Pipeline Future Projections and Market Disruptions	March 2006	£2230	9.8 %
Medical and Biological Sensors and Sensor Systems Markets, Applications, and Competitors Worldwide, 2nd Edition	May 2006	£2230	9.8 %
Emerging Cancer Vaccine Market, The 2nd Edition	November 2006	£2230	9.8 %
World Market for Prescription Generic Drugs; The 5th Edition	April 2006	£2230	9.8 %
Vaccines Market Insight Products, Pipelines & Market Outlook	January 2007	£1095	9.5 %
Optimizing Sales Force Effectiveness - From quantity to quality From quantity to quality	November 2006	£4000	9.45 %
Nanotechnology Opportunity Report, The	June 2003	£1330	9.45 %
Ono: Pipeline, Products, Performance, Potential	November 2007	£595	9.45 %
Bioinformatics Report The forecasts and future of the market 2006-2011	October 2006	£1499	9.45 %
The Global Pain Market 2008-2023	November 2008	£1499	9.45 %
Smoking Cessation Aids in Taiwan	December 2005	£450	9.45 %
Slovakia Pharmaceuticals & Healthcare	September 2006	£395	9.45 %
Medical Plastics to 2008	January 2005	£2610	9.45 %
UK Pharmaceuticals & Healthcare	September 2006	£395	9.45 %
Commercial Insight: Antihypertensives New challenges for a maturing market	September 2006	£8000	9.45 %
Medicinal Chemistry for Drug Discovery Significance of Recent Trends	March 2009	£2385	9.45 %
The Deployment of Antibody Technologies for the Advancement of Cancer Therapeutics	April 2008	£1965	9.45 %
Prospects for Legalizing Drug (Re-)Importation to the United States	June 2009	£970	9.45 %
OTC Healthcare - Serbia	April 2009	£750	9.45 %
Pharmaceutical Pricing And Reimbursement Strategies For Market Access Across The Us, Europe, Japan And Other Key Geographies	November 2007	£1495	9.45 %
Bristol-Myers Squibb Pipeline, Products, Performance, Potential	February 2008	£595	9.45 %
Biosimilars: Benchmarking the key players With increasing regulatory clarity and high revenue potential, interest in biosimilars increases	December 2006	£4000	9.45 %
The Indian Pharmaceutical Market Analysis and Forecasts 2008-2023	May 2008	£1499	9.1 %
All Change in the US Pharma Market?	June 2008	£995	9.1 %
Latin American Pharmaceutical Market Outlook To 2014 Policy environment, market analysis, forecasts and growth opportunities	November 2009	£3835	9.1 %
The Gastrointestinal Market Outlook To 2012	October 2007	£1495	9.1 %
Pharmacodiagnostics and Personalized Medicine 2009 (Markets, Challenges, Forecasts and Key Players)	April 2004	£2230	9.1 %
Global Market and Future Outlook for Neurodegenerative Disorder Therapies 2007, The	January 2007	£1430	9.1 %
Online Marketing and eDetailing Europe	July 2007	£75	9.1 %
Daiichi Sankyo: PharmaVitae Profile PharmaVitae Profile	January 2007	£3000	9.1 %
Pharma Sales World 2007: Advanced Sales Force Remodelling Strategies in a Multi-Channel Environment	January 2008	£75	9.1 %
Competitive Outlook on HCV What to Know & Expect in R&D and Business Development	June 2004	£870	9.1 %
Parallel Trade US Lawmakers Allow Imported Prescriptions Drugs	June 2007	£1499	9.1 %
Manufacturing in the Global Pharmaceuticals Industry Key drivers, company strategies and regulations (3rd Edition)	September 2008	£899	9.1 %
OTC market in Central and Eastern Europe 2008 Comparative analysis and development forecasts for 2008-2010	September 2008	£1745	9.1 %
Winning R&D Productivity Strategies Exploiting innovation, licensing and outsourcing opportunities	October 2006	£1495	9.1 %
Disease Management and Drug Adherence Strategies to support patients and enhance treatment persistence	July 2007	£3800	9.1 %
Innovations In Epigenetics Advances in Technologies, Diagnostics & Therapeutics	November 2009	£3835	9.1 %
Generic Option; The	July 2006	£440	9.1 %
Nycomed Pipeline Products Performance Potential	October 2007	£595	9.1 %
World Contract Research and Manufacturing Market, 2006-2011, The Trends in Outsourcing	August 2006	£1499	9.1 %
Pharmaceutical Outsourcing Opportunities Post-Launch Contract Manufacturing and Contract Sales and Marketing, 3rd Edition	January 2009	£2230	9.1 %
Emerging Pharmaceutical Markets Growth Opportunities, Changing Healthcare Dynamics And Regulatory Trends	September 2007	£1495	9.1 %
Complete Guide to the 2009 PPRS, NICE and other Pharmaceutical Cost Containment Measures in the United Kingdom	April 2009	£850	9.1 %
Indian Biopharmaceuticals Industry Report	January 2007	£400	9.1 %
The Future of Biobanks Regulation, ethics, investment and the humanization of drug discovery	March 2009	£2025	9.1 %
UK Complimentary & Alternative Medicines Market Development Report	May 2009	£600	9.1 %
Biotech 2010	June 2006	£3085	8.75 %
Innovative Drug R&D in China	October 2009	£1845	8.75 %
World Generics Market 2006-2011; The	May 2006	£1499	8.75 %
Mitsubishi Pharma: Pipeline, Products, Performance, Potential	October 2007	£595	8.75 %
Gilead Sciences Performance, Products, Pipeline and Potential	February 2008	£595	8.75 %
OTC Healthcare - Kazakhstan	April 2009	£750	8.75 %
Key Trends in Offshoring Pharmaceutical R&D Company strategies, emerging markets and impact on ROI	March 2009	£2025	8.75 %
Next-Generation Nutraceuticals Food and pharma convergence in disease prevention and personalized nutrition	December 2006	£1495	8.75 %
Emerging Markets Series: The Pharmaceutical Market of South Korea	October 2008	£4000	8.75 %
Medicated Skin Care in Taiwan	December 2005	£450	8.75 %
Eisai Pipeline - Products - Performance - Potential	June 2008	£595	8.75 %
Stakeholder Opinions Melanoma Lucrative commercial opportunities persist	October 2007	£3010	8.75 %
Pharmaceutical Wholesale and Distribution Industry Outlook & Analysis 2008, The	June 2008	£1499	8.75 %
Mid Pharma Sector In-licensing and other externalization strategies	June 2006	£4350	8.75 %
Stakeholder Opinions: Pancreatic Cancer - Gemzar dominance will continue among high levels of persistent unmet needs Healthcare	March 2009	£2000	8.75 %
OTC Healthcare in Cameroon	June 2008	£1200	8.4 %
Tanabe Prospects to 2010 Pipeline, Products,Performance,Potential	September 2007	£595	8.4 %
Cough, Cold and Allergy (Hayfever) Remedies in Taiwan	December 2005	£450	8.4 %
Wound Treatment in Belgium	November 2005	£450	8.4 %
Monoclonal Antibodies, Vaccines and Other Immunologic Cancer Treatments World Market	May 2007	£1270	8.4 %
Global. Generics	April 2009	£800	8.4 %
Pfizer Market Outlook for a Global Leader, 2008-2013	August 2008	£1499	8.4 %
United States Pharmaceuticals and Healthcare Report Q3 2006	July 2006	£395	8.4 %
Monoclonal Antibodies in Cancer Therapy 2009-2024	May 2009	£1499	8.4 %
Commercial Insight: Antidiabetics Patent expiries and cost containment initiatives balanced by pipeline products	August 2007	£8010	8.4 %
Contract Pharmaceutical Manufacturing, Research, and Packaging	August 2007	£3085	8.4 %
Nanotechnology in Health Care	February 2007	£2865	8.4 %
The Autoimmune Inflammatory Bowel Disease Market Outlook to 2012	February 2007	£1499	8.4 %
Otsuka Prospects to 2010	August 2007	£249	8.4 %
Latest Chinese Regulations for Imported Drug Registration China Pharmaceutical Guidebook	June 2008	£885	8.4 %
Pharmaceutical Strategic Alliances Maximizing returns from collaborative development and commercialization	September 2006	£1495	8.4 %
Astellas Pharma: Pipeline, Products, Performance, Potential	November 2007	£595	8.4 %
Commercial Insight: Antihormonal Cancer Therapies	July 2009	£15200	8.4 %
Digestive Remedies in Australia	July 2008	£450	8.05 %
Wound Treatments in Australia	July 2008	£450	8.05 %
Pediatric Drug Delivery Technology and Product Opportunities	February 2009	£1650	8.05 %
Stakeholder Opinions: Skin and soft tissue infections	July 2009	£3800	8.05 %
OTC market in Central and Eastern Europe 2009 Comparative analysis and development forecasts for 2009-2011	August 2009	£2180	8.05 %
Pipeline Insight: Breast Cancer Recent approvals increase pressure on pipeline candidates	April 2008	£6000	8.05 %
Healthcare in a Recession (OTC, Generics, Out of Pocket Spending, Healthcare Legislation, Retail Clinics, Outsourcing and Other Topics)	March 2003	£1270	8.05 %
Pharma Marketing ROI	January 2007	£75	8.05 %
AstraZeneca Pharmaceuticals, Company Profile and Healthcare	June 2008	£595	8.05 %
Emerging Generic Drug Markets in Europe	December 2007	£795	8.05 %
NRT Smoking Cessation Aids in Australia	July 2008	£450	8.05 %
Analgesics in Australia	July 2008	£450	8.05 %
World Generics Market, 2008-2013	November 2008	£1499	8.05 %
Shionogi: Pipeline - Products - Performance - Potential	March 2008	£595	8.05 %
Dermocosmetics market in Poland 2008 Development forecasts for 2008-2010	November 2008	£1485	8.05 %
Sales Force Effectiveness	September 2008	£4000	8.05 %
Outsourcing in Drug Discovery, 3rd Edition	May 2008	£1905	8.05 %
Commercial Insight: Depression Atypical lifecycle management strategy rejuvenates depression market	June 2007	£7600	8.05 %
Medical & Dental Adhesives & Sealants US industry forecasts to 2011 & 2016	May 2007	£2800	8.05 %
Pricing & Reimbursement - Seven Major Markets Update	May 2008	£2995	7.7 %
Top 10 Generic Pharmaceutical Companies, The Positioning, Performance and SWOT Analyses	July 2008	£1995	7.7 %
Monoclonal Antibodies 2007 Competitive Landscape & Pipeline Insight	January 2007	£1430	7.7 %
Medicated Skin Care in Australia	July 2008	£450	7.7 %
Reinventing Pharmaceutical Sales Forces	May 2009	£4900	7.7 %
Amgen Prospects to 2010	February 2009	£595	7.7 %
Commercial Insight: Osteoarthritis Market sees steady growth	December 2006	£8000	7.7 %
Pharmaceutical New Product Commercialization: Preparing for Market Success	May 2008	£3410	7.7 %
Pfizer Prospects to 2010 Pipeline, Products,Performance,Potential	September 2007	£595	7.7 %
Drug Safety for Marketed Drugs	April 2006	£75	7.7 %
OTC Healthcare in Azerbaijan	March 2009	£750	7.7 %
Vitamins and Dietary Supplements in Australia	July 2008	£450	7.7 %
Anti Infectives, Vol II: Antibacterials	April 2007	£1905	7.7 %
Innovative And Targeted Cancer Therapies Key Technologies, New Applications And Leading Players	July 2007	£1495	7.7 %
Mitsubishi: PharmaVitae Profile 2005	March 2006	£3295	7.7 %
Commercial Insight: Antidiabetics in Australia Reimbursement status shapes novel classes	October 2010	£5700	7.7 %
Accelerating Patient Recruitment in Clinical Trials	July 2006	£75	7.7 %
Major World Markets for Stents and The Economics of Drug-Eluting Technology	May 2008	£1780	7.7 %
Cardiovascular Generic Drugs Prospects and Opportunities to 2012	December 2007	£995	7.7 %
World Gastrointestinal Disorders Market 2006-2011; The	January 2006	£1799	7.7 %
Dr. Reddy's Market Outlook, Forecasts and Analysis to 2012	April 2007	£1499	7.7 %
Serono Prospects to 2010 Prospects to 2010	November 2006	£795	7.7 %
Monoclonal Antibodies Report Part II Companies - Holding Mabs In Portfolio Promises Protection Against The Looming 2011-12 Patent Cliff	September 2007	£3800	7.7 %
Pricing and Reimbursement: Innovative Risk-Sharing Strategies	July 2009	£3800	7.7 %
Licensing Strategies - Examining Todays Pharmaceutical Licensing Trends	November 2007	£7600	7.7 %
Option & Evaluation Agreements in Pharma and Biotech	March 2009	£995	7.5 %
CNS Drug Discoveries What the Future Holds	November 2006	£1995	7.35 %
Diabetes, Metabolic Syndrome and Cardiovascular Disease Reshaping Tomorrow's Diabetes Market	October 2005	£1270	7.35 %
European CME Forum: First Annual Meeting	February 2009	£75	7.35 %
World AMD and Diabetic Retinopathy Pharmaceutical Market 2009-2024	July 2009	£1499	7.35 %
Global Antivirals Market Analysis & Forecasts 2008-2023	September 2008	£1499	7.35 %
Global Medical Markets for Nanoscale Materials and Devices	January 2008	£3085	7.35 %
The Future of e-Clinical Trial Solutions Market Forecasts to 2015	December 2009	£2230	7.35 %
World Market for Biosimilars and the Potential for US Follow-on Biologics, The	August 2009	£2355	7.35 %
Clinical trials in Poland 2008 Development forecasts for 2008-2010	June 2008	£1375	7.35 %
Drug Targets for Breast Cancer	January 2006	£1095	7.35 %
Innovations in The Management of Diabetes Next generation treatments and market dynamics	June 2008	£1995	7.35 %
Health and Wellness Healthcare Products in South Korea	November 2006	£650	7.35 %
Dental Products in China Industry forecasts for 2012 & 2017	January 2009	£3245	7.35 %
Advanced Drug Delivery Systems: New Developments, New Technologies	October 2006	£3085	7.35 %
Commercial Opportunities from Biomarkers Transforming drug discovery, clinical development and molecular diagnostic	May 2006	£1495	7.35 %
Management of Urinary Incontinence and Overactive Bladder A Global Overview	June 2006	£8695	7.35 %
Monoclonal Antibodies Report Part I	June 2007	£3800	7.35 %
Indian Biopharmaceuticals	January 2008	£600	7.35 %
The Top 100 Molecular Diagnostics Manufacturing Companies Worldwide	March 2009	£605	7.35 %
Sanofi-aventis Pipeline, Products,Performance,Potential	September 2007	£249	7 %
The Top 10 Contract Research Organizations Positioning, performance and SWOT analyses	March 2009	£2025	7 %
Negotiating The Emerging Biosimilars Landscape Key Developments in The Regulatory Environment	February 2009	£2025	7 %
Clinical Trials: World Market 2009-2024	July 2009	£1499	7 %
Stakeholder Opinions: Diagnostics in Neurology Predictive Biomarkers Expand Drug Revenues	July 2008	£2005	7 %
Monoclonal Antibodies Report	June 2008	£3800	7 %
World Nutraceuticals to 2010	July 2006	£3500	7 %
World Sleep Disorders Market Analysis 2009-2024	June 2009	£1499	7 %
Contract Pharma 2008-2023	August 2008	£1499	7 %
Infection Prevention Products & Services	August 2009	£2990	7 %
Veterinary Health Markets	December 2008	£2165	7 %
Evolving Trends in Biopharmaceutical Licensing Deal assessments, drivers and resistors	March 2009	£2025	7 %
Global Ophthalmic Market Analysis & Forecasts to 2012	April 2007	£1499	7 %
Ophthalmological Therapeutics Pipelines, Delivery Technologies, and Markets	January 2008	£715	7 %
Anti Addiction Therapies, 2006-2011- The Pharmaceutical Industry's Next Viagra?	October 2006	£1499	7 %
Injectable Drug Delivery: Market Impact and Industry Trends	October 2006	£1115	7 %
Forecast Insight: Antidiabetics - Switching to new molecule antidiabetics drives market growth	August 2008	£7600	7 %
Biomanufacturing Strategies Market Drivers, Build-Vs-Buy Decisions And Opportunities In Contract Relationship Management	September 2007	£1495	7 %
Stakeholder Opinions: Head and Neck Cancer Innovatives to Change the Face of Treatment	November 2007	£2005	7 %
Partneringreview 2006 – Industry Sector Volume 6	February 2006	£1395	7 %
The Future of Targeted Therapeutics Key Technologies, New Therapy Area Applications and Leading Players	March 2008	£1995	7 %
Osteoporosis & Bone Metabolism Disorders Market 2008-2023	August 2008	£1499	7 %
United States Drug Delivery Devices Medical Equipment Industry Report Detailed Analysis of the Medical Equipment & Medical Devices Market Covering Infusion Systems, Inhalation Systems and Needle Free Injections Medical Equipment and Supplies	April 2008	£1910	7 %
Facial Rejuvenation Markets Worldwide	August 2008	£1265	7 %
Merger and Acquisition Agreements in Pharma, Biotech and Diagnostics	February 2009	£1195	6.65 %
Therapeutic Monoclonal Antibodies Report 2008-2023	July 2008	£1499	6.65 %
Global Clinical Trial Business Report & Analysis 2008-2018	July 2008	£1499	6.65 %
Market for Bioengineered Protein Drugs; The	January 2007	£3085	6.65 %
The Pharmaceutical Industry 2008 Current and Future Trends and Strategic Issues Shaping Pharma	March 2008	£3010	6.65 %
Pipeline Insight: Colorectal Cancer Growing trend towards personalized medicine	October 2010	£11400	6.65 %
World Market for Prescription Cardiovascular Drugs 2nd Edition	November 2007	£2545	6.65 %
Colorectal Cancer: Pipeline/Commercial Insight Shaping the future dynamics of colorectal cancer management	October 2006	£8000	6.65 %
Stakeholder Opinions Novel Therapeutic Approaches in Cardiovascular Medicine - Lack of Market Prospects for Biologics Expose An Opportunity for Cell and Gene Therapies	July 2008	£3800	6.65 %
Nanotechnology in Life Science Applications	October 2005	£3085	6.65 %
Genomics World Markets	May 2008	£2165	6.65 %
Indian Pharmaceutical Industry	July 2008	£1270	6.65 %
Global Generics Guide Benchmarking the key players	April 2006	£4000	6.65 %
Therapeutic Peptides in Oncology Favorable Conditions But Where to Commercialize?	May 2009	£3010	6.65 %
Merck KGaA - OTC Healthcare - World	January 2008	£195	6.65 %
U.S. Market for IV Therapy and Vein Access	August 2006	£3085	6.65 %
Medicated Skin Care in Venezuela	February 2008	£450	6.65 %
Emerging Markets For Microfluidic Applications EMMA Report 2009 Emerging Markets for Microfluidic Applications in Life Sciences and In-Vitro Diagnostics	August 2009	£3480	6.65 %
Winning Product Launch Strategies Maximizing sales from new pharmaceutical products	April 2007	£1495	6.65 %
World Asthma and COPD Treatment Market, 2006-2011, The A Changing Market with Increasing Potential	September 2006	£1499	6.65 %
Pricing and Reimbursement in Japan Costly healthcare system inefficiencies increase the focus on healthcare cost containment	November 2006	£2005	6.65 %
Cadinal Health Medical Device Company Intelligence Report	April 2008	£395	6.3 %
Cancer Biomarkers Enhancing diagnostic, therapeutic and developmental strategies	May 2006	£2195	6.3 %
Commercial Insight: Antithrombotics Market expands as disease management focuses on prevention	October 2007	£7600	6.3 %
Forecast Insight: Dyslipidemia - Genericization and negative trial data drive market shrinking	August 2008	£7600	6.3 %
Valuing Pharmaceutical Innovation Pricing and Reimbursement for Innovative Therapies	July 2008	£1995	6.3 %
Anti-Obesity Treatments 2007-2012 - A blockbuster target market	July 2007	£1799	6.3 %
U.S. Market for Gastrointestinal Pharmaceuticals	September 2005	£3085	6.3 %
Wyeth Prospects to 2010 Performance, Products, Pipeline and Potential	July 2007	£595	6.3 %
Sleep Disorders Insomnia, Sleep Apnea, Restless Leg Syndrome, Bruxism, Narcolepsy and Sleepwalking	March 2009	£2165	6.3 %
Stakeholder Opinions: Osteoarthritis Preconceptions Damage Awareness and Treatments	March 2006	£2195	6.3 %
Avian Influenza	August 2006	£635	6.3 %
CNS Biomarkers: Players, products and prospects (Volume II)	August 2008	£595	6.3 %
China Pharma Outsourcing Market By 2015	January 2009	£1110	6.3 %
Commercial Insight: Cardiovascular market overview Raft of patent expires threaten blockbusters	October 2007	£7600	6.3 %
Non-pharmacy OTC market in Poland 2008 Development forecasts for 2008-2010	April 2008	£1035	6.3 %
Biosimilars: a viable market?	September 2008	£1295	6.3 %
Partnering Agreements In Diagnostics Trends in diagnostics partnering deals Diagnostic partnering agreement structure Diagnostic partnering contract document	September 2009	£1195	6.3 %
Pricing and Reimbursement in Key Asia Pacific Markets	January 2009	£2000	6.3 %
Online Pharmaceutical Industry, 2006-2011, The	July 2006	£1499	6.3 %
Chinese Markets for Health Care	November 2006	£2545	6.3 %
Live-Licensing & In-life Testing R&D Processes and Regulation for New Drugs, 2008-2020	January 2008	£1499	6.3 %
Gene Expression Reagents Markets	April 2007	£1270	5.95 %
Taq Wars; The Competitive Intelligence on How to Survive	November 2005	£2865	5.95 %
OTC Healthcare in Uruguay	July 2008	£1200	5.95 %
Stakeholder Insight: Supportive Care in Cancer Treatment Some first-generation products proving difficult to dislodge	October 2006	£8000	5.95 %
Fastest Growing Biotechnology Companies, The Growth Strategies, Comparative Analyses and Company Profiles	March 2008	£1995	5.95 %
Commercial Insight: Top 20 Cancer Therapy Brands Sales of targeted therapies overtake cytotoxics in 2006	July 2007	£7600	5.95 %
Emerging Opportunities in Inhalation & Nasal Spray Generic Drugs	May 2007	£995	5.95 %
Nanotechnology Revolutionizing R&D to Develop Smarter Therapeutics and Diagnostics	January 2008	£1995	5.95 %
UK Drug Delivery Devices Investment Opportunities Analysis and Forecasts to 2012	September 2008	£1910	5.95 %
Global Generics Guide: Part 2 Benchmarking country markets and strategic issue	June 2006	£8695	5.95 %
Infection Prevention Products & Services to 2009	July 2005	£2610	5.95 %
Organ Transplant Immunosuppressive Markets	January 2008	£2230	5.95 %
Drug Approval Trends at the FDA and EMEA Process Improvements, Heightened Scrutiny and Industry Response	April 2008	£1995	5.95 %
Commercial Insight: Antidyslipidemics Branded statins beware, generics are amongst you	July 2006	£8440	5.95 %
Rx to OTC Switches 2009	April 2004	£2545	5.95 %
Health and Wellness Healthcare Products in Finland	December 2006	£650	5.95 %
Retail Clinics and The in-Store Healthcare Market 2009 Bright Spot in The Current Economy?	March 2009	£2230	5.95 %
Clinical Stage Partnering Agreements in Biopharma	June 2008	£1295	5.95 %
Separation Systems for Commercial Biotechnology	February 2007	£3085	5.95 %
World Generic Market Report 2007	November 2006	£595	5.6 %
Commercial Insight: Cardiovascular and metabolic market overview Diabetes to the fore as generics hit primary care markets	February 2009	£8000	5.6 %
Stakeholder Insight: Acute Stroke - TPA spurs infrastructure changes for the better Healthcare	October 2007	£7600	5.6 %
Pipeline Insight: Insulin Antidiabetics Return to Injections Alternative Delivery Methods Fall by The Wayside	July 2008	£6000	5.6 %
M&A trends in Pharma	October 2008	£6000	5.6 %
Herbal Supplements, Prescription Drugs, Rx-to-OTC Products A Comparison	October 2006	£3085	5.6 %
Pharmacovigilance Risk Management in Practice	July 2006	£1499	5.6 %
Spain Drug Delivery Devices Investment Opportunities, Analysis and Forecasts to 2012	May 2008	£1910	5.6 %
Future Growth Opportunities in Generics The impact of consolidation on market and competitive dynamics	November 2006	£1495	5.6 %
The U.S. Market for EMR Technologies	January 2007	£2545	5.6 %
Pipeline Insight: Orphan Diseases in CNS - Part I: Huntington's Disease	November 2007	£3800	5.6 %
Gastrointestinal Disorders Market Intelligence to 2012	May 2007	£1499	5.6 %
Forecast Insight: HIV	June 2009	£15200	5.6 %
World Respiratory Disorders Market 2009-2024	June 2009	£1499	5.6 %
The US Pharmaceutical Market 2009-2024	November 2009	£1499	5.6 %
Innovation in Drug Delivery The future of nanotechnology and non-invasive protein delivery	November 2006	£1495	5.6 %
Global Cardiovascular Drugs Market 2009-2024	June 2009	£1499	5.6 %
Immunotherapy of Cancer	March 2007	£3085	5.6 %
Wireless in Healthcare 2008 The Market for Bluetooth, Rfid, Zigbee, Uwb Wwan, Wman, WLAN and Other Technologies	May 2008	£2230	5.6 %
OTC Healthcare in Slovenia	February 2009	£750	5.6 %
Stakeholder Opinions: Cancer Cachexia Higher profile needed to unlock market potential of neglected syndrome	January 2009	£2000	5.6 %
Schering AG Prospects to 2010	November 2006	£895	5.6 %
Partneringreview 2006 – Stage of Development Volume 4	February 2006	£1395	5.5 %
Partneringreview 2006 – Deal Type Volume 5	February 2006	£1395	5.5 %
Partneringreview 2006 – Therapy Area Volume 2	February 2006	£1395	5.5 %
Partneringreview 2006 – Financings Volume 3	February 2006	£1395	5.5 %
Partneringreview 2006	February 2006	£2195	5.5 %
China Drug Delivery Devices Investment Opportunities, Analysis and Forecasts to 2012	May 2008	£1910	5.25 %
Weight Control Products and Services to 2008	February 2005	£2480	5.25 %
Biophotonics A Strategic Assessment of Photonics Technologies for Biomedical Applications	November 2006	£1905	5.25 %
The Global Pain Therapeutics Market Market Analysis, R&D Pipelines and Competitive Landscape	October 2007	£1910	5.25 %
Biotech Drug Delivery Systems Key Company Intelligence & Market Outlook to 2012	February 2007	£1299	5.25 %
Pipeline Insight: Antiarrhythmics RSD1235 in a class of its own	May 2006	£6495	5.25 %
Biomarker Technology Platforms for Cancer Diagnoses and Therapies	April 2008	£2165	5.25 %
Parkinson's Disease Market analysis and forecasts 2008-2012, 2017 & 2022	January 2008	£1499	5.25 %
Nanomedicine 2006-2011	June 2006	£1499	5.25 %
Commercial Insight: Epilepsy Companies Committed To The Cause Will Reap The Benefits	September 2007	£7600	5.25 %
Medical Imaging Markets, Volume II Magnetic Resonance	September 2006	£1905	5.25 %
Blood The Worldwide Market for Blood Products, Blood Testing, Blood Equipment, and Synthetic Blood Products	September 2006	£2480	5.25 %
Medical Imaging Markets, Volume III Ultrasound	October 2006	£1905	5.25 %
Forecast Insight: Opioids - Saturation limits the commercial potential of individual brands Healthcare	March 2009	£8000	5.25 %
Wireless Opportunities in Healthcare The Market for Bluetooth, RFID, Zigbee, UWB WWAN, WMAN, WLAN and other technologies	January 2007	£2545	5.25 %
Pipeline/Commercial Insight: Antihypertensives New class opportunity offset by key patent expiries	July 2007	£7600	5.25 %
Critical Care Pharmaceutical Markets A Strategic Analysis	June 2006	£1905	5.25 %
Worldwide Point of Care (POC) Are Decentralized Clinical Diagnostics a Cost Drain or Revenue Driver?	November 2006	£1905	5.25 %
Reducing Medical Error and Improving Diagnostics through Digital Imaging (Review Report)	February 2007	£1795	5.25 %
Impact of Pharmacogenomics on Public Healthcare Policy Educating Patients, Payors and Healthcare Providers	March 2008	£1995	5.25 %
Mass Spectrometry in Protein Biomarker Applications Software, Services, and Instrument Markets	November 2006	£1905	5.25 %
Stakeholder Opinions: Small Cell Lung Cancer and Malignant Mesothelioma Limited R&D activity provides opportunity for early-phase pipeline drugs	March 2007	£2005	5.25 %
The World Diabetes Market, 2007-2025 An Analysis of Diabetes Drug and Insulin Market	March 2009	£225	5.25 %
Pricing and Reimbursement in the US Innovation and robust pharmacoeconomic analysis are ke	June 2006	£6495	5.25 %
Launch Strategies - Analyzing Market Trends and Regulatory Impacts	August 2007	£8010	5.25 %
Medical Ultrasound Systems Market Worldwide. 2009	July 2009	£1590	5.25 %
Pediatric Drugs: the Worldwide Market 3rd Edition	December 2007	£2545	5.25 %
Partneringreview 2006 - Company Deal Index Volume 1	February 2006	£1395	5 %
Stakeholder Opinions: Hepatocellular Carcinoma Opportune indication for novel therapies	June 2007	£3800	4.9 %
Commercial Insight: Asthma & COPD	June 2009	£15200	4.9 %
Infectious Diseases Drugs Markets	October 2009	£2165	4.9 %
Commercial and Pipeline Insight: ADHD Immature adult market continues to offer greatest commercial potential	April 2008	£8000	4.9 %
Rx-to-OTC Strategies Maximizing The Commercial Potential of An Rx-to-OTC Switch	June 2008	£2995	4.9 %
Modern Biopharmaceuticals Design, Development and Optimization, 4 Volumes	September 2005	£440	4.9 %
Global Vaccines Market 2008-2023, The	August 2008	£1499	4.9 %
Disposable Syringe Markets Trends, Industry Participants, Product Overviews and Market Drivers	October 2009	£2165	4.9 %
Women's Health Market Outlook to 2011	May 2007	£1495	4.9 %
Global Image Dermatology Drug Market, 2005-2012, The High-Growth Opportunities in Aesthetic Medicine	November 2005	£795	4.9 %
Stakeholder Opinion: Atopic Dermatitis A high level of unmet need creates market opportunities	March 2007	£2005	4.9 %
Global Market for Antimicrobials and Antifungals; The Challenging Resistance to 2016	December 2006	£1600	4.9 %
Immunomodulators Therapeutic Needs, Pipelines & Prospects	August 2007	£1495	4.9 %
RNA Interference Markets	December 2008	£2165	4.9 %
U.S. Market for Over-the-Counter Pediatric Medication and Healthcare Products	March 2006	£1910	4.9 %
Pipeline Insight: Orphan Diseases in Neurology Part III: Myasthenia Gravis	November 2008	£6000	4.9 %
Commercial Insight: Antihormonal Therapy Cancer Brands Careful Lifecycle Management Needed to Preserve Brand Dominance	August 2008	£7600	4.9 %
The World Dermatological Market Outlook 2010-2024	November 2009	£1499	4.9 %
The Dermatology Market Outlook to 2011	March 2007	£1495	4.9 %
Companion Biomarkers in Drug Development	April 2009	£2165	4.9 %
Akzo Nobel Prospects to 2010	October 2006	£795	4.9 %
Next Generation Protein Engineering and Drug Design Strategies to boost efficacy and improve drug delivery	February 2007	£1495	4.55 %
Global Protein Therapeutics Market, The Market Dynamics and Pipeline Analysis	December 2006	£1910	4.55 %
Stakeholder Insight: Pricing and Reimbursement in Oncology Do payers believe oncology drugs offer good value?	December 2006	£6000	4.55 %
The Global Anti-Infectives Market Outlook to 2011	June 2007	£1495	4.55 %
Chemotherapy Market Insights, 2006-2016 A Critical Analysis of Cancer Research, Treatments, Pipelines, and Commercial Opportunities	April 2006	£1900	4.55 %
Stakeholder Opinions: Tuberculosis - Development pipeline shows signs of life Healthcare	March 2009	£2000	4.55 %
Small Molecule Kinase Inhibitors	July 2009	£2515	4.55 %
The Future of Metabolic Disorder Therapeutics Market Forecasts to 2015	December 2009	£2230	4.55 %
Commercial Insight: Antidyslipidemics The competitive cost-conscious antidyslipidemics market presents challenges	July 2007	£7600	4.55 %
Drug Discovery Tools for High-Content Analysis	July 2007	£1270	4.55 %
Commercial Insight: Neuropathic Pain A Plethora of Patient Segmentation and Product Differentiation Opportunities	July 2006	£8440	4.55 %
Commercial Insight Top 20 Cancer Therapeutics	July 2006	£8695	4.55 %
Stakeholder Opinions: Back Pain Gain competitive edge by targeting subpopulations	March 2009	£2000	4.55 %
Multiplex Assays in Translational Medicine Technologies, Applications, and Future Directions	February 2008	£715	4.55 %
Injectable Generic Drugs Prospects & Opportunities to 2013	July 2008	£1295	4.55 %
The Cardiovascular Disorders Market Outlook to 2012	February 2008	£1995	4.55 %
Targeting the Healthy Consumer Fast growth markets and future trends	September 2006	£995	4.55 %
The Global Antivirals Market R&D Pipelines, Market Analysis and Competitive Landscape	May 2007	£1590	4.55 %
Molecular Diagnostics Markets	September 2008	£2165	4.55 %
In Vitro Diagnostics Market Report & Analysis 2008-2023	June 2008	£1499	4.55 %
Disposable Medical Supplies US industry forecasts for 2013 & 2018	July 2009	£3055	4.55 %
Stakeholder Opinions: Hormonal Contraceptives New directions in a competitive market	November 2006	£2005	4.55 %
Low-Cost RFID Smart Labels International Markets & Opportunities in Europe & North America	January 2007	£1745	4.2 %
United States Drug Delivery Devices Investment Opportunities Analysis and Forecasts to 2012	September 2008	£1910	4.2 %
Stakeholder Opinions: Bladder Cancer New drugs needed to challenge ineffective 20 year old drugs	November 2008	£2000	4.2 %
Pipeline Insight: Upper GI Disorders - Generics will limit pipeline profit	July 2007	£6000	4.2 %
Disposable Medical Supplies Markets	August 2009	£2165	4.2 %
Commercial & Pipeline Insight: Hospital Antibacterials A market beyond MRSA	August 2007	£8010	4.2 %
Cell-Based Assays for Drug Discovery	August 2009	£2165	4.2 %
Strategic Perspectives: Antidyslipidemics Current market is not conducive for growth	October 2008	£8000	4.2 %
Therapeutics for Memory and Cognition Disorders	April 2009	£3085	4.2 %
Gene Expression Profiling Markets	January 2008	£2545	4.2 %
Pipeline Insight: Non-insulin Antidiabetics Type 2 diabetes unlikely to develop into a switch market	August 2006	£6495	4.2 %
World Generic Market Report 2009	January 2009	£595	4.2 %
Commercial Insight: Migraine Opportunities Will Exist In The Wake Of Generic Attack	September 2007	£7600	4.2 %
Top Companies and Products in the RNA/DNA Therapy Products Market Forecasts: The Challenge Of Turning Technology Into Therapy	July 2007	£1999	4.2 %
Pipeline Insight: Heart failure Week pipeline dominated by new indications and add-on diuretics	August 2007	£6000	4.2 %
Stakeholder Opinions: Cystic Fibrosis - A pipeline full of hope Healthcare	March 2009	£2000	4.2 %
Pricing & Reimbursement in Europe Can the drive for cost effectiveness overcome cost containment?	October 2006	£6000	4.2 %
UK Healthcare IT Investment Opportunities Analysis and Forecasts to 2012	September 2008	£1910	4.2 %
Point of Care Diagnostic Testing Sector Trends	June 2009	£2165	4.2 %
Dietary supplements market in Poland 2009 Development forecasts 2009-2011	March 2009	£1310	4.2 %
Cardiotoxicity: Issues, Technologies, and Solutions for the Future	May 2008	£2385	4.2 %
CNS Generic Drugs: Prospects and Opportunities to 2012	April 2008	£995	4.2 %
Generic League Market Analysis and Forecasts, 2007-2012, 2017 & 2022	February 2008	£1999	4.2 %
World Dermatological Market Outlook, 2009-2023, The	January 2009	£1499	4.2 %
Pipeline Insight: Acute Stroke Commercial Risk Offsets High Unmet Need	May 2008	£6000	4.2 %
Commercial Insight: Asthma & COPD Combination Products Still Have Blockbuster Potential	July 2007	£7600	4.2 %
Cancer Therapeutics: The Worldwide Market The Worldwide Market , 2nd Editon	February 2007	£2545	4.2 %
Stakeholder Opinions: Physician perception of biologics in autoimmune disease - Targeted detailing is the key to success Healthcare	March 2009	£2000	3.85 %
Analysis of the Pharmaceutical Market to 2012 - Segmented by Drug Target Family Sales & Marketing	October 2007	£3800	3.85 %
Animal Biotechnology Technologies, Markets and Companies	February 2010	£1590	3.85 %
Biosimilars and Follow-On Biologics Report The Global Outlook 2009-2024	April 2009	£1499	3.85 %
Pipeline and Commercial Insight: Osteoporosis Novel agents to battle for payer acceptance	July 2009	£15200	3.85 %
DNA Sequencing and PCR Markets	July 2007	£2165	3.85 %
Patient Monitoring Markets	October 2009	£2165	3.85 %
Proteomics Technologies, Markets and Companies	February 2010	£2865	3.85 %
Cancer Cell Therapy Markets	March 2008	£2165	3.85 %
Stakeholder Opinions: Primary Brain Cancer Temozolomide Turns Heads	July 2007	£2005	3.85 %
Global Biotech Market Analysis and Forecasts, 2008-2023	August 2008	£1499	3.85 %
Laparoscopic Devices Market Research Report Worldwide	June 2009	£1270	3.85 %
Bioinformatics Markets Strategies, Business Models and Trends for the Future	March 2009	£2165	3.85 %
Hematology Analyzer Instrumentation and Reagent Markets	July 2009	£2165	3.85 %
Stakeholder Insight: Alzheimer's Disease Prescribing trends indicate that neurologists are not adhering to guidelines	December 2006	£8000	3.85 %
Drug Treatments for Leading Endocrine and Metabolic Diseases	February 2007	£3085	3.85 %
China Pharma Outsourcing Annual Review 2009	November 2009	£880	3.85 %
Sleep Apnea Diagnostic & Therapeutic Devices Worldwide	August 2008	£1590	3.85 %
The World Market for Gynaecology 2007-2017	September 2007	£3200	3.5 %
Companion Diagnostics in Personalized Medicine and Cancer Therapy	April 2008	£2165	3.5 %
Pipeline Insight: Neuropathic Pain Emerging Drugs Fail To Capitalize In Lucrative Market	September 2007	£740	3.5 %
Pipeline Insight: Benign Prostatic Hyperplasia - Novel therapeutics and reformulations will drive market growth	April 2009	£6000	3.5 %
Pipeline/Commercial Insight: Supportive Care in Oncology Significant growth opportunities exist in new supportive care indications	June 2007	£7600	3.5 %
Pipeline Insight: Non-insulin antidiabetics Incretin mimetics leaders in a diverse pipeline	May 2008	£6000	3.5 %
Autoimmune Disease Therapeutics	July 2009	£2515	3.5 %
Anti-Obesity Treatments Analysis & Forecasts 2009-2024	February 2009	£1499	3.5 %
Forecast Insight: Multiple Sclerosis Tysabri to prevail despite safety setbacks	August 2008	£7600	3.5 %
Stakeholder Insight: Osteoporosis Generic alendronate further establishes oral bisphosphonates as gold standard	October 2008	£8000	3.5 %
All Change in the Advanced Wound Care Market 2009	May 2009	£795	3.5 %
Bioinformatics Technical Status and Market Prospects	August 2005	£3085	3.5 %
Quality for Biologics Critical quality attributes, process and change control, product variation, characterisation, and regulatory concerns	December 2008	£1495	3.5 %
Commercial and Pipeline Insight: Systemic antifungals	November 2007	£7600	3.5 %
Biomarkers Technologies, Markets and Companies	February 2010	£2865	3.5 %
Pipeline and Commercial Insight: Schizophrenia - Second generation depots protect market value	October 2008	£8000	3.5 %
Competitive Outlook of Cancer Drug Development The Missing Handbook to New Product Planning and Portfolio Planning	August 2009	£2140	3.5 %
Cancer Diagnostic Testing World Markets	April 2008	£2165	3.15 %
Nitric Oxide Therapeutics, Markets and Companies	February 2010	£1780	3.15 %
Stakeholder Insight: Psoriasis Biologics are yet to make topical treatments obsolete	March 2009	£8000	3.15 %
Nanomaterials Markets by Type	December 2005	£3085	3.15 %
Commercial Insight: Pain Market Overview Non-Traditional Analgesics and Opioid Reformulations to Sustain Sector Growth	October 2008	£8000	3.15 %
Medical Nanotechnology Markets	September 2008	£2165	3.15 %
Stakeholder Insight Asthma - over-Prescribing Is Common in Intermittent and Mild Forms of Asthma	July 2008	£7600	3.15 %
Pipeline and Commercial Insight: Anxiety Disorders Viable indication for antipsychotics companies	November 2008	£8000	3.15 %
Pipeline And Commercial Insight Pediatric And Adolescent Vaccines	July 2007	£8000	3.15 %
Membrane Bioreactors	July 2009	£2515	3.15 %
Lung Cancer Therapeutics	July 2009	£2515	3.15 %
Pipeline Insight: Non-Small Cell Lung Cancer Pipeline set to offer only modest improvements	April 2008	£6000	3.15 %
Rimonabant: The first of the Cannabinoid blockbusters	June 2007	£1499	3.15 %
Incremental Improvements And Paradigm Shifts In Strategy Are Both Necessary To Boost Productivity R&D Strategies	August 2007	£7600	3.15 %
Pipeline Insight: Osteoarthritis The Wait for a DMOAD Continues	November 2006	£6000	2.8 %
Worldwide Optical, Transmission TEM, and Scanning SEM Electron Microscope Market Shares, Strategies, and Forecasts 2009 to 2015	February 2009	£2165	2.8 %
Pain Therapeutics Drugs, Markets and Companies	February 2010	£2230	2.8 %
Pipeline Insight: Molecular Targeted Cancer Therapies More pipeline activity, less product differentiation	November 2008	£8000	2.8 %
Protein Therapeutics Market; The The Science and Business of a Growing Sector	June 2006	£2480	2.8 %
Pipeline Insight: Hematological Malignancies Companies target niche indications to facilitate market entry	April 2009	£6000	2.45 %
Nanomedicine	July 2009	£2515	2.45 %
Personalized Medicine Scientific & Commercial Aspects	February 2010	£2545	2.1 %
RNAi Technologies, Markets and Companies	February 2010	£2230	2.1 %
Point of Care Diagnostic Testing World Markets	November 2009	£2165	2.1 %
Antiviral Therapeutics Technologies, Markets and Companies	February 2010	£2035	2.1 %
Nanobiotechnology Applications, Markets and Companies	February 2010	£2865	2.1 %
Pipeline and Commercial Insight: Nicotine Dependence - Chantix issues overshadow vaccine potential Healthcare	March 2009	£8000	2.1 %

Search Results

Results for 'UK Pharmaceutical Executive Pay'

Bookmark this Product